Rajiv Jalan
#105,933
Most Influential Person Now
Researcher
Rajiv Jalan's AcademicInfluence.com Rankings
Rajiv Jalancomputer-science Degrees
Computer Science
#3874
World Rank
#4071
Historical Rank
Artificial Intelligence
#790
World Rank
#802
Historical Rank
Database
#1124
World Rank
#1181
Historical Rank
Download Badge
Computer Science
Rajiv Jalan's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Rajiv Jalan Influential?
(Suggest an Edit or Addition)Rajiv Jalan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. (2013) (2069)
- Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) (2009) (906)
- Acute-on chronic liver failure. (2012) (765)
- Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. (2014) (723)
- Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. (2015) (672)
- Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. (2014) (617)
- Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. (2004) (463)
- Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure (2016) (455)
- Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis (2015) (455)
- Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: The RELIEF trial (2013) (443)
- Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis (2011) (370)
- Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment (2008) (356)
- Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure (1999) (339)
- A histologic scoring system for prognosis of patients with alcoholic hepatitis. (2014) (337)
- Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis (2017) (324)
- Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. (2015) (323)
- Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications (2013) (316)
- Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome (2007) (290)
- Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options (2002) (272)
- Acute-on-chronic liver failure in cirrhosis (2016) (258)
- Targeting the gut-liver axis in liver disease. (2017) (254)
- Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. (2004) (253)
- The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. (2015) (251)
- Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. (2008) (238)
- Intensive care of the patient with cirrhosis (2011) (236)
- Acute-on-chronic liver failure (2015) (233)
- Management of the critically ill patient with cirrhosis: A multidisciplinary perspective. (2016) (231)
- Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions (2012) (228)
- Pathophysiological effects of albumin dialysis in acute‐on‐chronic liver failure: A randomized controlled study (2004) (228)
- Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: A multicenter survey on safety and efficacy (2013) (225)
- Toward an improved definition of acute-on-chronic liver failure. (2014) (224)
- Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites (2015) (223)
- Role of ammonia and inflammation in minimal hepatic encephalopathy (2007) (222)
- The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation (2005) (217)
- Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. (2003) (209)
- Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS (2002) (209)
- Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality (2009) (204)
- The pathophysiological basis of acute-on-chronic liver failure. (2002) (198)
- A randomized trial comparing transjugular intrahepatic portosystemic stent‐shunt with variceal band ligation in the prevention of rebleeding from esophageal varices (1997) (195)
- Endotoxemia produces coma and brain swelling in bile duct ligated rats (2007) (194)
- Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. (2004) (192)
- Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. (1999) (188)
- Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. (2019) (183)
- Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. (2016) (182)
- Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. (2015) (181)
- Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. (2003) (179)
- Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis. (2008) (179)
- Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. (1995) (176)
- Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation. (2019) (167)
- Aromatic amino acid metabolism during liver failure. (2007) (159)
- Tumour necrosis factor α is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis (2003) (156)
- Evaluation of coagulation abnormalities in acute liver failure. (2012) (156)
- Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. (2019) (152)
- Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure (2000) (149)
- Ammonia impairs neutrophil phagocytic function in liver disease (2008) (147)
- The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology (120/120). (2020) (146)
- Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. (2011) (146)
- Interorgan ammonia metabolism in liver failure (2002) (142)
- UK guidelines on the management of variceal haemorrhage in cirrhotic patients (2000) (140)
- The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis. (2011) (140)
- Protocols and Mechanisms for Remote Ischemic Preconditioning: A Novel Method for Reducing Ischemia Reperfusion Injury (2007) (136)
- Albumin in decompensated cirrhosis: new concepts and perspectives (2020) (130)
- Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. (2019) (129)
- L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy. (2007) (124)
- Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. (2020) (122)
- Hepatic encephalopathy: a critical current review (2017) (121)
- Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B. (2016) (121)
- Albumin in chronic liver disease: structure, functions and therapeutic implications (2015) (120)
- Acute-on-Chronic Liver Failure. (2020) (119)
- The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis (2003) (119)
- Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? (1997) (118)
- Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic (2020) (116)
- Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia (2001) (114)
- The Systemic Inflammation Hypothesis: Towards a New Paradigm of Acute Decompensation and Multiorgan Failure in Cirrhosis. (2020) (114)
- Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension (2007) (113)
- Remote ischaemic preconditioning of the hind limb reduces experimental liver warm ischaemia–reperfusion injury (2006) (112)
- Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis (2003) (112)
- Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis (2007) (111)
- Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis (2007) (111)
- Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis. (2000) (110)
- Interorgan ammonia metabolism in liver failure: the basis of current and future therapies (2011) (109)
- Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study (2012) (108)
- Dispelling myths in the treatment of hepatic encephalopathy (2005) (107)
- Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. (2012) (107)
- Intracranial hypertension in acute liver failure: pathophysiological basis of rational management. (2003) (106)
- A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. (1995) (106)
- Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis. (2005) (104)
- Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis. (2016) (103)
- Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in acute liver failure. (2002) (102)
- Urea cycle dysregulation in non-alcoholic fatty liver disease. (2018) (101)
- Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy (2004) (99)
- Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson's disease (2002) (98)
- Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis (2019) (98)
- PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. (2020) (98)
- Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid. (2004) (96)
- Inflammation and portal hypertension - the undiscovered country. (2014) (93)
- Acute liver failure: current management and future prospects. (2005) (93)
- Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial (2018) (92)
- L‐ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats (2009) (92)
- Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol‐related acute‐on‐chronic liver failure (2015) (91)
- L‐ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure (2009) (91)
- The molecular pathogenesis of hepatic encephalopathy. (2003) (91)
- Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis (2013) (90)
- Emerging Indications for Albumin Dialysis (2005) (89)
- Interorgan ammonia trafficking in liver disease (2009) (89)
- Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure (2018) (87)
- Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: A randomized study* (2006) (87)
- Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis. (2009) (85)
- Beyond scoring: a modern interpretation of disease progression in chronic liver disease (2013) (84)
- Hepatic encephalopathy and ascites (1997) (83)
- PROSPECTS FOR EXTRACORPOREAL LIVER SUPPORT (2004) (81)
- Infection and inflammation in liver failure: two sides of the same coin. (2009) (80)
- A PILOT STUDY OF INDOCYANINE GREEN CLEARANCE AS AN EARLY PREDICTOR OF GRAFT FUNCTION (1994) (80)
- Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure (2007) (79)
- Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. (1996) (78)
- Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study. (2017) (78)
- Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension. (2016) (78)
- Sepsis in alcohol-related liver disease. (2017) (76)
- A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS) (1997) (75)
- Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. (1997) (75)
- Treatment of Phenytoin Toxicity by the Molecular Adsorbents Recirculating System (MARS) (2003) (74)
- Acute-on-chronic liver failure in patients with alcohol-related liver disease. (2019) (73)
- Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit? (2017) (73)
- Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs (2004) (72)
- Acute-on-Chronic Liver Failure: Definition, Diagnosis, and Clinical Characteristics (2016) (71)
- Equilibrium contrast-enhanced CT imaging to evaluate hepatic fibrosis: initial validation by comparison with histopathologic sampling. (2015) (71)
- Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy (2001) (70)
- Patients With Acute on Chronic Liver Failure Grade 3 Have Greater 14‐Day Waitlist Mortality Than Status‐1a Patients (2019) (68)
- Effect of the clinical course of acute on chronic liver failure prior to liver transplantation on post-transplant survival. (2020) (68)
- Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure. (2015) (67)
- Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box? (2007) (66)
- Ammonia and Hepatic Encephalopathy: The More Things Change, the More They Remain the Same (2005) (65)
- Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems. (1998) (64)
- Renal dysfunction in cirrhosis is not just a vasomotor nephropathy (2014) (64)
- Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function. (1999) (64)
- Transjugular intrahepatic portosystemic stent-shunt (TIPSS) occlusion and the role of biliary venous fistulae. (1996) (63)
- Importance of Connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failure. (2013) (63)
- Orchestration of Tryptophan‐Kynurenine Pathway, Acute Decompensation, and Acute‐on‐Chronic Liver Failure in Cirrhosis (2019) (62)
- Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure. (2020) (62)
- Paracetamol: are therapeutic doses entirely safe? (2006) (61)
- Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. (1997) (61)
- Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension. (2015) (58)
- quantitative tests of liver function (1995) (58)
- Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure (2005) (57)
- Role of aquaporin-4 in the development of brain oedema in liver failure. (2010) (56)
- Short chain fatty acids exchange: Is the cirrhotic, dysfunctional liver still able to clear them? (2010) (55)
- Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical study (2015) (54)
- Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy (2016) (53)
- Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS). (2021) (53)
- Role of Toll‐Like Receptor 4 in Mediating Multiorgan Dysfunction in Mice With Acetaminophen Induced Acute Liver Failure (2013) (53)
- Review article: the Molecular Adsorbents Recirculating System (MARS) in liver failure (2002) (52)
- Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis. (2018) (52)
- Artificial liver support systems in the management of complications of cirrhosis. (2008) (51)
- Effect of toll‐like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma (2014) (51)
- Management of hepatic encephalopathy in patients with cirrhosis. (2007) (51)
- Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver (2003) (51)
- Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis (2000) (51)
- 1184 EXTRACORPOREAL LIVER SUPPORT WITH THE MOLECULAR ADSORBENT RECIRCULATING SYSTEM (MARS) IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (AOCLF). THE RELIEF TRIAL (2010) (50)
- Isoleucine infusion during “simulated” upper gastrointestinal bleeding improves liver and muscle protein synthesis in cirrhotic patients (2007) (50)
- Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis. (2007) (49)
- Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure (2007) (49)
- [232] ALBUMIN INFUSION FOR SEVERE HYPONATREMIA IN PATIENTS WITH REFRACTORY ASCITES: A RANDOMIZED CLINICAL TRIAL (2007) (48)
- Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models. (1996) (48)
- Impaired brain glymphatic flow in experimental hepatic encephalopathy (2018) (48)
- Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity (2018) (48)
- Altered peripheral vascular responses to exogenous and endogenous endothelin‐1 in patients with well‐compensated cirrhosis (2001) (48)
- Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute‐on‐chronic liver failure patients (2016) (47)
- Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome. (2019) (47)
- Hemostasis in patients with acute kidney injury secondary to acute liver failure. (2013) (47)
- ‘Out‐patient’ albumin dialysis for cholestatic patients with intractable pruritus (2012) (46)
- Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease (2020) (46)
- Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury (2015) (45)
- Cirrhosis-associated immune dysfunction (2021) (45)
- Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome (2007) (45)
- The inflammatory basis of intracranial hypertension in acute liver failure. (2001) (45)
- Hyperammonemia and Systemic Inflammatory Response Syndrome Predicts Presence of Hepatic Encephalopathy in Dogs with Congenital Portosystemic Shunts (2014) (45)
- Prognostic Role of Ammonia in Patients With Cirrhosis (2019) (44)
- A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt. (1995) (44)
- Interorgan ammonia, glutamate, and glutamine trafficking in pigs with acute liver failure. (2006) (44)
- Ammonia reduction with ornithine phenylacetate restores brain eNOS activity via the DDAH-ADMA pathway in bile duct-ligated cirrhotic rats. (2012) (43)
- TIPSS 10 years on (2000) (42)
- Liver failure: basis of benefit of therapy with the molecular adsorbents recirculating system. (2003) (42)
- Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide (2003) (42)
- Mechanism of cell death in acute‐on‐chronic liver failure: a clinico‐pathologic‐biomarker study (2015) (42)
- Transjugular intrahepatic portosystemic stent-shunt (TIPSS): long-term follow-up. (1994) (41)
- Laparoscopy and histology in the diagnosis of chronic liver disease. (1995) (41)
- Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis. (2003) (40)
- Oral Amino Acid Load Mimicking Hemoglobin Results in Reduced Regional Cerebral Perfusion and Deterioration in Memory Tests in Patients with Cirrhosis of the Liver (2004) (40)
- Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats. (2014) (40)
- Cell death markers in cirrhotic patients with acute decompensation (2017) (40)
- Dogs with congenital porto-systemic shunting (cPSS) and hepatic encephalopathy have higher serum concentrations of C-reactive protein than asymptomatic dogs with cPSS (2012) (39)
- Reduction in hyperammonaemia by ornithine phenylacetate prevents lipopolysaccharide‐induced brain edema and coma in cirrhotic rats (2011) (39)
- Acute liver failure: liver support therapies (2007) (39)
- Acute-on-Chronic Liver Failure: Recent Concepts. (2015) (39)
- Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic stent‐shunt (TIPSS) (1996) (39)
- Cell death markers in patients with cirrhosis and acute decompensation (2018) (39)
- Acute endotoxemia following transjugular intrahepatic stent-shunt insertion is associated with systemic and cerebral vasodilatation with increased whole body nitric oxide production in critically ill cirrhotic patients. (2011) (39)
- Understanding hepatic encephalopathy (2018) (38)
- Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis. (2016) (38)
- Clinical and Pathophysiological Consequences of Alterations in the Microbiome in Cirrhosis (2015) (37)
- Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure (2000) (37)
- Management of Hepatic Encephalopathy (2011) (37)
- Liver Transplantation for Acute‐on‐Chronic Liver Failure: Science or Fiction? (2020) (36)
- Extracorporeal Liver Support (2012) (36)
- Treatment of uncontrolled intracranial hypertension in acute liver failure with moderate hypothermia (1999) (36)
- Acute liver failure: a review. (2006) (35)
- Prediction of cirrhosis in patients with chronic hepatitis C infection by artificial neural network analysis of virus and clinical factors (1998) (35)
- Kidney plays a major role in ammonia homeostasis after portasystemic shunting in patients with cirrhosis. (2006) (35)
- pathogenesis and treatment of chronic hepatic encephalopathy (1996) (34)
- Effective albumin concentration and cirrhosis mortality: from concept to reality. (2013) (34)
- Review article: quantitative tests of liver function. (1995) (34)
- French Intensive Care Society, International congress – Réanimation 2016 (2016) (33)
- Dynamic Prognostication in Critically Ill Cirrhotic Patients With Multiorgan Failure in ICUs in Europe and North America: A Multicenter Analysis* (2018) (33)
- Binding of bilirubin and bromosulphthalein to albumin: Implications for understanding the pathophysiology of liver failure and its management (2004) (33)
- Longterm Outcomes of Patients Undergoing Liver Transplantation for Acute‐on‐Chronic Liver Failure (2020) (33)
- Liver Replacement Therapy (2012) (32)
- Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study (2018) (32)
- The treatment of hepatic encephalopathy (2007) (32)
- Is minimal hepatic encephalopathy completely reversible following liver transplantation? (2004) (32)
- How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist (2015) (31)
- Extracorporeal liver support devices for listed patients (2016) (31)
- Circulating microRNAs Reveal Time Course of Organ Injury in a Porcine Model of Acetaminophen-Induced Acute Liver Failure (2015) (30)
- Primary prophylaxis of variceal bleeding in cirrhosis. (2001) (30)
- The role of duplex and colour Doppler ultrasound in the follow-up evaluation of transjugular intrahepatic portosystemic stent shunt (TIPSS). (1995) (30)
- A model to study total hepatic ischemia-reperfusion injury. (2004) (30)
- Neurological complications of acute liver failure: Pathophysiological basis of current management and emerging therapies (2012) (30)
- A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis. (2017) (29)
- Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit. (2016) (29)
- Systemic and regional haemodynamics in pigs with acute liver failure and the effect of albumin dialysis (2006) (29)
- Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity (2019) (29)
- Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis. (2018) (29)
- Hypothermia in Acute Liver Failure (2004) (28)
- Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease (2017) (27)
- Design, Analysis, and Pitfalls of Clinical Trials Using Ex Situ Liver Machine Perfusion: The International Liver Transplantation Society Consensus Guidelines (2021) (27)
- Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding. (2020) (27)
- Acute on Chronic Liver Failure From Nonalcoholic Fatty Liver Disease: A Growing and Aging Cohort With Rising Mortality (2020) (26)
- Patients with severe acute‐on‐chronic liver failure are disadvantaged by model for end‐stage liver disease‐based organ allocation policy (2020) (26)
- Prognostic Role of Ammonia in Cirrhotic Patients (2019) (25)
- Characterisation of temporal microglia and astrocyte immune responses in bile duct‐ligated rat models of cirrhosis (2014) (25)
- Transjugular intrahepatic portosystemic stent-shunt in the management of gastric and ectopic varices (2006) (25)
- Gap junctions in liver disease: Implications for pathogenesis and therapy. (2019) (25)
- PTU-008 A reproducible, clinically-relevant, intensively-managed, pig model of acute liver failure for testing of therapies aimed to prolong survival (2012) (25)
- Recombinant Alkaline Phosphatase Prevents Acute on Chronic Liver Failure (2020) (24)
- Natural history of acute decompensation of cirrhosis: The basis of the definition, prognosis and pathophysiology of acute on chronic liver failure (2006) (24)
- Quality of life measures predict mortality in patients with cirrhosis and severe ascites (2018) (24)
- Induction of cerebral hyperemia by ammonia plus endotoxin: does hyperammonemia unlock the blood-brain barrier? (2007) (24)
- Infliximab and alcoholic hepatitis (2004) (24)
- Short-term abstinence from alcohol and changes in cardiovascular risk factors, liver function tests and cancer-related growth factors: a prospective observational study (2018) (23)
- Role of artificial liver support in hepatic encephalopathy (2009) (23)
- Extracorporeal albumin dialysis in acute‐on‐chronic liver failure: Will it stand the test of time? (2002) (23)
- Improvement in cerebral perfusion after MARS therapy: Further clues about the pathogenesis of hepatic encephalopathy? (2001) (23)
- MARS: A new treatment for hepatorenal failure (2000) (23)
- Nitric oxide and L-arginine metabolism in a devascularized porcine model of acute liver failure. (2012) (23)
- Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF. (2020) (22)
- Obesity is independently associated with infection in hospitalised patients with end‐stage liver disease (2015) (22)
- Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis (2017) (22)
- New clinical and pathophysiological perspectives defining the trajectory of cirrhosis. (2021) (22)
- Neutrophil elastase: a determinant of endothelial damage and reperfusion injury after liver transplantation? (1996) (22)
- Acute-on-Chronic Liver Failure: A Distinct Clinical Condition (2016) (21)
- Caval Subtraction 2D Phase-Contrast MRI to Measure Total Liver and Hepatic Arterial Blood Flow: Proof-of-Principle, Correlation With Portal Hypertension Severity and Validation in Patients With Chronic Liver Disease (2016) (21)
- Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality. (2020) (21)
- Hypothermia for the Management of Intracranial Hypertension in Acute Liver Failure (2001) (21)
- Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF (2021) (21)
- Mechanistic biomarkers in acute liver injury: are we there yet? (2012) (21)
- L-Ornithine phenylacetate reduces ammonia in pigs with acute liver failure through phenylacetylglycine formation: a novel ammonia-lowering pathway. (2014) (21)
- Pharmacotherapy for hyperammonemia (2014) (21)
- The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS) (2017) (21)
- Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS) (1996) (21)
- Treatment of hyperammonemia in liver failure: a tale of two enzymes. (2009) (21)
- Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90‐day mortality (2019) (21)
- Not all mice are the same: Standardization of animal research data presentation (2016) (20)
- Transjugular intrahepatic portosystemic stent shunt. (1995) (20)
- The brain in acute on chronic liver failure (2014) (20)
- Review article: pathogenesis and treatment of chronic hepatic encephalopathy. (1996) (20)
- Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis (2012) (19)
- Review article: renal circulatory changes in cirrhosis‐‐pathogenesis and therapeutic prospects. (1996) (19)
- Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis. (2022) (19)
- The puzzle of endothelial nitric oxide synthase dysfunction in portal hypertension: The missing piece? (2007) (19)
- The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure (2004) (19)
- Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper (2022) (19)
- Patients with PBC have central but no peripheral fatigue (1996) (19)
- Impact of transjugular intrahepatic portosystemic stent-shunt for secondary prophylaxis of oesophageal variceal haemorrhage: a single-centre study over an 11-year period (2002) (19)
- Arterial ammonia levels in cirrhosis are determined by systemic and hepatic hemodynamics, and by organ function: a quantitative modelling study (2014) (18)
- Relationship between directly measured portal pressure gradient and variceal hemorrhage. (1995) (18)
- Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation. (2021) (18)
- Transjugular intrahepatic portosystemic stent-shunt (TIPSS) insertion as a prelude to orthotopic liver transplantation in patients with severe portal hypertension (1996) (18)
- A Double-Blind, Randomized Placebo-Controlled Trial of Probiotic Lactobacillus casei Shirota in Stable Cirrhotic Patients (2020) (18)
- Treatment of hyperammonemia in liver failure (2013) (18)
- Association between hepatic histopathologic lesions and clinical findings in dogs undergoing surgical attenuation of a congenital portosystemic shunt: 38 cases (2000-2004). (2011) (17)
- Caecal ligation and puncture induced sepsis in the rat results in increased brain water content and perimicrovessel oedema (2014) (17)
- Novel insights into ammonia‐mediated neurotoxicity pointing to potential new therapeutic strategies (2014) (17)
- Liver: The gut is a key target of therapy in hepatic encephalopathy (2015) (17)
- Attenuation of Congenital Portosystemic Shunt Reduces Inflammation in Dogs (2015) (17)
- Plasma cytokine concentrations in dogs with a congenital portosystemic shunt. (2014) (17)
- Systemic and regional changes in plasma endothelin following transient increase in portal pressure (2003) (17)
- Treatment of hepatic encephalopathy: It's not lactulose (2004) (16)
- Risk of intentional reversible thrombosis of transjugular intrahepatic portosystemic shunt. (1995) (16)
- Shunt insufficiency after transjugular intrahepatic portosystemic stent-shunt: the whens, whys, hows and what should we do about it? (1997) (16)
- Development of an organ failure score in acute liver failure for transplant selection and identification of patients at high risk of futility (2017) (16)
- 1404 DIAGNOSIS, PREVALENCE, AND PROGNOSIS OF ACUTE-ON- CHRONIC LIVER FAILURE (ACLF): RESULTS OF THE EASL-CHRONIC LIVER FAILURE (CLIF) CONSORTIUM CANONIC STUDY (2012) (16)
- Transjugular intrahepatic portasystemic stent—shunt in the treatment of variceal haemorrhage (1995) (16)
- Interorgan metabolism of ornithine phenylacetate (OP)--a novel strategy for treatment of hyperammonemia. (2013) (16)
- O15 EFFECTS OF THE FXR AGONIST OBETICHOLIC ACID ON HEPATIC VENOUS PRESSURE GRADIENT (HVPG) IN ALCOHOLIC CIRRHOSIS: A PROOF OF CONCEPT PHASE 2A STUDY (2014) (16)
- Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival (2017) (15)
- Acute-on-chronic liver failure. (2020) (15)
- Acute-on-chronic liver failure: an early biopsy is essential? (2010) (15)
- Hepatic guanylate cyclase activity is decreased in a model of cirrhosis: A quantitative cytochemistry study (2006) (14)
- Hepatic encephalopathy (2022) (14)
- SARS-CoV-2 infection and liver involvement (2022) (14)
- Review article: hyperammonaemic and catabolic consequences of upper gastrointestinal bleeding in cirrhosis (2009) (14)
- Endotoxin measures in patients' sample: how valid are the results? (2007) (14)
- Acute changes in cerebral blood flow and metabolism during portasystemic shunting (2001) (14)
- Rifaximin in hepatic encephalopathy: more than just a non-absorbable antibiotic? (2010) (14)
- In vivo hepatic magnetic resonance spectroscopy: clinical or research tool? (1996) (13)
- 'Equity' and 'justice' for patients with acute-on chronic liver failure: A call to action. (2021) (13)
- Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding (2004) (13)
- Hypothermia for the management of intracranial hypertension in acute liver failure (2001) (13)
- Acute-on-chronic liver failure: from concept to a new syndrome. (2011) (13)
- Pros and cons of L-arginine supplementation in disease (2004) (12)
- The impact of obesity in cirrhotic patients with septic shock: A retrospective cohort study (2018) (12)
- Ornithine phenylacetate revisited (2013) (12)
- P476 SHORT-TERM (28-DAY) CLINICAL COURSE AND TRANSPLANT-FREE MORTALITY IN ACUTE ON CHRONIC LIVER FAILURE (ACLF); EVIDENCE FOR REVERSIBILITY OF ACLF (A STUDY FROM THE CANONIC DATABASE) (2014) (12)
- Metabolism and Effects on Endogenous Metabolism of Paracetamol (Acetaminophen) in a Porcine Model of Liver Failure (2020) (12)
- British Association for the Study of the Liver (1991) (11)
- Clinical and cytokine response to anti-TNF antibody therapy in severe alcoholic hepatitis. (2001) (11)
- Cracking the ENCODE: From transcription to therapeutics (2013) (11)
- Correlation of the intracranial pressure to the central venous pressure in the late phase of acute liver failure in a porcine model. (2012) (11)
- Long‐term outcome in patients with acute liver failure (2018) (11)
- Baseline SOFA score and its lack of early improvement accurately predicts mortality in patients with acute-on-chronic liver failure. (2004) (11)
- Gc‐globulin to predict outcome in acute liver failure: A panacea? (2005) (11)
- Delayed opioid withdrawal-like reaction in primary biliary cirrhosis following naloxone therapy. (2001) (10)
- O091 : Oral therapy with non-absorbable carbons of controlled porosity (YAQ-001) selectively modulates stool microbiome and its function and this is associated with restoration of immune function and inflammasome activation (2015) (10)
- Brain lactate in hepatic encephalopathy: friend or foe? (2014) (10)
- A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices (1998) (10)
- Early transplantation maximizes survival in severe acute-on-chronic liver failure: Results of a Markov decision process model (2021) (10)
- MELD remains the best predictor of mortality in outpatients with cirrhosis and severe ascites (2020) (9)
- Acute‐on‐Chronic Liver Failure: A New Disease or an Old One Hiding in Plain Sight? (2020) (9)
- Protein synthesis is severely diminished following a simulated upper GI bleed in patients with cirrhosis. (2008) (9)
- Hepatic encephalopathy: New treatments (2015) (9)
- Abnormal brain oxygen homeostasis in an animal model of liver disease (2022) (9)
- Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease (2020) (9)
- Efficacy of balloon angioplasty, restenting, and parallel shunt insertion for shunt insufficiency after transjugular intrahepatic portosystemic stent-shunt (TIPSS) (1998) (9)
- Post-Transcriptional Regulation of Hepatic DDAH1 with TNF Blockade Leads to Improved eNOS Function and Reduced Portal Pressure In Cirrhotic Rats (2017) (9)
- Bio-artificial liver support for acute liver failure: should we be using it to treat patients? (2002) (9)
- Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute‐on‐chronic liver failure and acute decompensation (2020) (9)
- Urotensin II: better than somatostatin for portal hypertension? (2000) (9)
- The role of RIPK1 mediated cell death in acute on chronic liver failure (2021) (8)
- Plasma Lipid Profiling in a Rat Model of Hepatocellular Carcinoma: Potential Modulation Through Quinolone Administration. (2015) (8)
- Influence of cyclic guanosine monophosphate changes on hemodynamics after reperfusion in liver transplantation. (1997) (8)
- A multi-journal partnership to highlight joint first-authors of manuscripts. (2015) (8)
- Novel approaches and therapeutics in acute‐on‐chronic liver failure (2016) (8)
- Effect of the FXR Agonist Obeticholic acid on portal pressure in alcoholic cirrhosis: A proof of concept Phase 2a study (2012) (8)
- Improving Survival in Patients with Decompensated Cirrhosis (2011) (7)
- Changes in cerebral metabolism in patients with acute liver failure (ALF) and uncontrolled intracranial hypertension treated with moderate hypothermia (1998) (7)
- Artificial liver support: Overview of Registry and controlled clinical trials (2003) (7)
- To pee or not to pee: ammonia hypothesis of hepatic encephalopathy revisited (2011) (7)
- Untargeted lipidomics uncovers lipid signatures distinguishing severe versus moderate forms of acutely decompensated cirrhosis. (2021) (7)
- An Accurate Data Preparation Approach for the Prediction of Mortality in ACLF Patients using the CANONIC Dataset (2019) (7)
- Alfapump® System versus Large Volume Paracentesis in the Treatment of Refractory Ascites; Results from a Multicenter Randomised Controlled Study (Rct) (2016) (7)
- SYSTEMIC HEMODYNAMICS, HEPATIC BLOOD FLOW AND PORTAL PRESSURE IN PATIENTS WITH CIRRHOSIS AND MULTIORGAN FAILURE: THE ROLE OF SYSTEMIC INFLAMMATORY RESPONSE AND SYMPATHETIC ACTIVATION (2008) (7)
- Partial MCT1 invalidation protects against diet-induced non-alcoholic fatty liver disease and the associated brain dysfunction. (2022) (7)
- TIPSS trials: Design determines outcome (1997) (7)
- Continuous low flow ascites drainage through the urinary bladder via the Alfapump system in palliative patients with malignant ascites (2019) (7)
- Not All Mice Are the Same: Standardization of Animal Research Data Presentation (2016) (7)
- Terlipressin-induced vasoconstriction reversed with N-acetylcysteine: a case for combined use in hepatorenal syndrome? (2002) (7)
- Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure (2021) (7)
- Hypercoagulability progresses to hypocoagulability during evolution of acetaminophen-induced acute liver injury in pigs (2017) (7)
- Acute‐on‐Chronic Liver Failure: A Distinct Clinical Syndrome That Has Reclassified Cirrhosis (2019) (7)
- Primary biliary cholangitis has the highest waitlist mortality in patients with cirrhosis and acute on chronic liver failure awaiting liver transplant (2021) (6)
- The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation. (2019) (6)
- MARS: a new treatment for hepatorenal failure. Molecular adsorbent and recirculating system. (2000) (6)
- Overt hepatic encephalopathy is an independent risk factor for de novo infection in cirrhotic patients with acute decompensation (2022) (6)
- Early increase in ammonia is a feature of non-alcoholic fatty liver disease and the ammonia lowering drug, ornithine phenylacetate (OCR-002) prevents progression of fibrosis in a rodent model (2017) (6)
- THE DEVELOPMENT AND TESTING OF THE UCL LIVER SUPPORT DEVICE (UCL-ARSENEL): IMPROVEMENT OF SURVIVAL IN PARACETAMOL-INDUCED ACUTE LIVER FAILURE PIGS (2010) (6)
- Systems Biology of the Liver (2012) (6)
- Hyperammonaemia induces mitochondrial dysfunction and neuronal cell death (2022) (6)
- Mars in decompensated alcoholic liver disease with multi-organ failure. (2001) (6)
- P0187 : A Randomized controlled trial comparing the alfapump© with paracentesis in patients with refractory ascites: Clinical and pathophysiological effects on cardiac, haemodynamic, inflammatory, renal and nutritional parameters (2015) (6)
- Laparoscopy in the diagnosis of chronic liver disease. (1995) (6)
- Not All Mice Are the Same: Standardization of Animal Research Data Presentation. (2016) (6)
- Corrigendum to "Targeting the gut-liver axis in liver disease" [J Hepatol 67 (2017) 1084-1103]. (2018) (6)
- Extracorporeal albumin dialysis for intoxication from protein-bound agents. (2004) (6)
- PWE-141 Alfa pump for the treatment of refractory ascites: a “real world” experience from the uk (2015) (6)
- Diagnosis of hepatic encephalopathy: Will in vivo proton MRS play a role? (1999) (6)
- Location and allocation: Inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe (2022) (6)
- Heretical thoughts into Hepatic Encephalopathy. (2022) (6)
- Expression of TLR-2 in hepatocellular carcinoma is associated with tumour proliferation, angiogenesis and Caspase-3 expression. (2020) (6)
- Ideal hepatocyte: Quest for the Holy Grail (2005) (5)
- 173 Pathophysiological basis of extracorporeal albumin dialysis with MARS in acute-on-chronic liver failure due to alcohol (2003) (5)
- Corrigendum to "Management of the critically ill patients with cirrhosis: A multidisciplinary perspective". (2016) (5)
- Portosystemic Shunt Embolization and Recurrent Ascites: A Single-Center Case Series. (2018) (5)
- Neurocritical Care Management of Hepatic Encephalopathy and Coma in Liver Failure (2018) (5)
- PMO-128 Effects of oral nanoporous carbon therapy in leptin null mice as a model of non-alcoholic steatohepatitis (2012) (5)
- Genetic variants of innate immunity receptors are associated with mortality in cirrhotic patients with bacterial infection (2020) (5)
- Reversal of severe cholestasis caused by chronic graft-versus-host disease with the MARS liver-support device. (2003) (5)
- Albumin regeneration for extracorporeal liver support using prometheus: a step in the right direction. (2012) (5)
- Consensus care recommendations for alfapump® in cirrhotic patients with refractory or recurrent ascites (2022) (5)
- Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation (2022) (5)
- 9. Acute-on-chronic liver failure (2015) (5)
- Blood–brain barrier in liver failure: are cracks appearing in the wall? (2010) (5)
- Organ allocation for patients with acute-on-chronic liver failure: Time to look beyond MELD-sodium? (2020) (5)
- A Call for Randomization in Clinical Trials of Liver Machine Perfusion Preservation (2020) (5)
- Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF. (2022) (5)
- REDUCTION IN RENAL BLOOD-FLOW WITH ACUTE INCREASE IN PORTAL PRESSURE-GRADIENT - EVIDENCE FOR THE HEPATORENAL REFLEX (1994) (5)
- Should a biopsy precede liver resection or transplantation for presumed hepatocellular carcinoma when the alfa fetoprotein is normal? (2004) (5)
- TREATMENT WITH INFLIXIMAB INCREASES E-NOS ACTIVITY IN CIRRHOSIS THROUGH MODULATION OF THE DDAH-ADMA PATHWAY (2009) (5)
- Alcoholic Liver Diseases (2005) (4)
- Corrigendum to “Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites” [J Hepatol 2015;62:968–974] (2015) (4)
- 801 Brain production of pro-inflammatory cytokines in patients with acute liver failure and uncontrolled intracranial hypertension: evidence of disrupted blood brain barrier? (2003) (4)
- LP35 : A placebo-controlled, multicenter, double-blind, randomised, pharmacokinetic and pharmacodynamic trial of emricasan (IDN-6556) in subjects with acute-on chronic liver failure (ACLF) (2015) (4)
- THE MECHANISM BEHIND SYNERGISTIC ACTION OF LORNITHINE AND PHENYLACETATE TO REDUCE AMMONIA IN CIRRHOTIC RATS (2010) (4)
- PTH-095 Oral carbon therapy is associated with a selective modulation of the microbiome in cirrhotic rats which is associated with a significant reduction in inflammatory activation (2015) (4)
- Acute-on-Chronic Liver Failure. Reply. (2020) (4)
- Alcohol and Acute-on-Chronic Liver Failure. (2021) (4)
- Asian Pacific Association for Study of the Liver (APASL) (2003) (4)
- Prognostic role of liver biopsy in patients with severe indeterminate acute hepatitis. (2021) (4)
- Congenital glutamine deficiency with glutamine synthetase mutations. (2006) (4)
- Emerging trends in hepatology: 30 years of the Journal of Hepatology and 50 years of EASL. (2015) (4)
- Acute Liver Failure: Pathophysiologic Basis, and The Current and Emerging Therapies (2014) (4)
- Transjugular intrahepatic portosystemic stent-shunt insufficiency and the role of diabetes mellitus (1998) (4)
- Lipopolysaccharide-Induced Neutrophil Dysfunction Following Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Insertion is Associated with Organ Failure and Mortality (2017) (4)
- Reply to: “Is a liver biopsy necessary in alcoholic hepatitis?” (2012) (4)
- Ornithine transcarbamylase gene expression and hepatic urea nitrogen handling are reduced in models of NAFLD and recovers with dietary modulation and reducing bacterial translocation : Rationale for ammonia lowering therapy in NASH patients ( Max 255 ) (2015) (4)
- Obeticholic acid, a Farensoid‐X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats (2014) (4)
- Acute-on Chronic Liver Failure (ACLF): A distinct clinical syndrome (2012) (4)
- Differing actions of the acute administration of propranolol and isosorbide‐5‐mononitrate on the portal circulation (1996) (4)
- Journal of Hepatology: the home of liver research. (2015) (4)
- Serum albumin shows conformational, structural and functional abnormalities in cirrhotic patients, which worsen with severity of liver disease and are unaffected by albumin dialysis (2005) (3)
- Diagnosis and Treatment of Low-Grade Hepatic Encephalopathy (2015) (3)
- O74 URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IS A STRONG PREDICTOR OF SHORT-TERM OUTCOME IN PATIENTS WITH ACUTE DECOMPENSATION OF CIRRHOSIS. RELATIONSHIP WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) (2014) (3)
- Noradrenaline Potentiates Portal Hypertension through the Alpha 2a Adrenergic Receptor – A target for Therapy in Portal Hypertension (2016) (3)
- Not All Mice Are the Same: Standardization of Animal Research Data Presentation (2016) (3)
- TIPS OUTCOMES FOR BUDD-CHIARI: A SINGLE TERTIARY CENTRE EXPERIENCE (2011) (3)
- P508 VALIDATION OF THE CLIF-CONSORTIUM (CLIF-C) SCORE TO PREDICT MORTALITY OF PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) IN AN EXTERNAL COHORT AND FOR SEQUENTIAL MEASUREMENTS (2014) (3)
- The analysis of acetaminophen (paracetamol) and seven metabolites in rat, pig and human plasma by U(H)PLC-MS. (2020) (3)
- Increased cerebral and peripheral vasodilation, and whole body nitricoxide (NO) production after insertion of a transjugular intrahepatic portosystemic stent-shunt (TIPSS) in patients with cirrhosis (2002) (3)
- From the Editor's desk...: July 2016. (2016) (3)
- Alcohol takes the toll on immune function (2010) (3)
- Body fat composition determines outcomes before and after liver transplantation in patients with cirrhosis (2022) (3)
- PLASMA FROM STABLE PATIENTS WITH CIRRHOSIS TRANSMITS SEVERE NEUTROPHIL PHAGOCYTIC DYSFUNCTION WHICH IS INDEPENDENT OF THE PRESENCE OF BACTERIAL DNA AND ASSOCIATED WITH INCREASED EXPRESSION OF TLR-4 (2009) (3)
- Enhanced renal ammonia production is major cause of hyperammonemia after a simulated upper gastrointestinal bleed in patients with cirrhosis of the liver (1999) (3)
- Inhibition of TLR7 and TLR9 Reduces Human Cholangiocarcinoma Cell Proliferation and Tumor Development (2021) (3)
- 'Eastern type' of Acute-on-chronic Liver Failure (ACLF) is similar in pathophysiologic, diagnostic and prognostic criteria to the 'Western type': A comparison of Chinese hospitalized patients with Hepatitis B with CANONIC data (2014) (3)
- Correction to 'Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF' [J Hepatol 2020 (72) 688-701]. (2020) (3)
- P076 A multi-centre, randomized controlled study, to evaluate the safety and performance of the DIALIVE liver dialysis device in patients with acute on chronic liver failure (ACLF) versus standard of care (SOC) (ALIVER Consortium) (2021) (3)
- Fatty Hepatocytes Induce Skeletal Muscle Atrophy In Vitro: A New 3D Platform to Study the Protective Effect of Albumin in Non-Alcoholic Fatty Liver (2022) (3)
- Prognostic value of C-reactive protein in patients with cirrhosis: external validation from the CANONIC cohort (2014) (3)
- Contractile response of femoral arteries in pigs with acute liver failure (2004) (3)
- Gastric mucosal bleeding time in cirrhosis. (1994) (3)
- Short Term Abstinence from Alcohol Improves Insulin Resistance and Fatty Liver Phenotype in Moderate Drinkers (2015) (3)
- The Lipopolysaccharide-Sensing Caspase(s)-4/11 Are Activated in Cirrhosis and Are Causally Associated With Progression to Multi-Organ Injury (2021) (3)
- PS-149-Recombinant glutamine synthetase: A novel strategy for the treatment of hyperammonemia and consequent hepatic encephalopathy in rodent model of cirrhosis and urea cycle enzyme deficiency (2019) (3)
- A multi-journal partnership to highlight joint first-authors of manuscripts (2015) (3)
- Editorial: alfapump—an alternative to large‐volume paracentesis for patients with refractory ascites? (2018) (3)
- Randomised controlled trial of transjugular intra-hepatic portosystemic stent-shunt (TIPSS) versus tipss and variceal band ligation (VBL) in the prevention of variceal rebleeding (2001) (3)
- P1319 : Alfapump® system versus large volume paracentesis in the treatment of refractory ascites. A multicenter randomised controlled study (2015) (3)
- Reply to: Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation: unanswered questions LTE 19-00600 DC. (2019) (3)
- Update on extracorporeal liver support. (2020) (3)
- Reply to: "Acute-on-chronic liver failure - its definition remains unclear". (2013) (2)
- 581 GUT DECONTAMINATION USING NANOPOROUS CARBONS REDUCES PORTAL PRESSURE AND PREVENTS LIVER FAILURE IN BILE-DUCT LIGATED CIRRHOTIC ANIMALS BY REDUCING KUPFFER CELL ACTIVATION (2012) (2)
- Evaluation of the CLIF-C ACLF score in critically ill cirrhotic patients in intensive care units in Europe and North America: a multicenter cohort study (2017) (2)
- TIPSS trials: Design determines outcome - Comments (1997) (2)
- There Is a Great Future in Plastics: Personalized Approach to the Management of Hilar Cholangiocarcinoma Using a 3-D-Printed Liver Model (2020) (2)
- Evaluation of CirrhoCare® - A digital-health solution for home management of patients with cirrhosis. (2022) (2)
- Long-Term Outcomes of Everolimus Therapy in De Novo Liver Transplantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2021) (2)
- Evaluation of the biomarker, dimethylarginine score-ischemia modified albumin ratio (DASIMAR) to identify risk of progression to acute on chronic liver failure and mortality (ACLF) in patients with decompensated cirrhosis (2007) (2)
- Pulmonary vascular clearance of harmful endogenous macromolecules in a porcine model of acute liver failure. (2016) (2)
- 787 Worsening of cerebral hyperemia in acute liver failure with severe hepatic encephalopathy following terlipressin (2003) (2)
- 1083 MARS treatment improves renal function independent of systemic haemodynamics in acute liver failure: a randomized controlled study in a pig model (2003) (2)
- Mathematical Model of Ammonia Handling in the Rat Renal Medulla (2014) (2)
- When to use renal replacement therapy and bioartificial support for renal failure in patients with cirrhosis (2013) (2)
- PMO-127 Biological effects of oral nanoporous carbon in bile duct ligated rats (2012) (2)
- P077 Pathophysiological basis of resolution of acute-on-chronic liver failure (ACLF) induced by the novel liver dialysis device, DIALIVE (ALIVER consortium) (2021) (2)
- THU-036-First description of the immune checkpoint receptor landscape in decompensated cirrhosis and ACLF (2019) (2)
- Effect of transjugular intrahepatic portosystemic stent-shunt (TIPSS) upon liver function in patients with cirrhosis (1997) (2)
- Increased cerebral and peripheral vasodilation, and whole body nitric oxide production after insertion of a transjugular intrahepatic portal-systemic stent in patients with cirrhosis. (2003) (2)
- 1414 THE CLIF-CONSORTIUM SCORE PREDICTS MORTALITY MORE ACCURATELY THAN THE MELD AND MELD-SODIUM SCORES IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CIRRHOSIS WITH AND WITHOUT ACUTE-ON-CHRONIC-LIVER FAILURE (ACLF). (2013) (2)
- P35 Treatment with an Alpha 2a Adrenoreceptor Antagonist Modulates Hepatic Inflammation, Markedly Reduces Portal Pressure, and Improves Arterial Pressure and Hepatic Blood Flow in Cirrhotic Rats (2010) (2)
- Hepatic Cirrhosis (2018) (2)
- 'OUT-PATIENT' ALBUMIN DIALYSIS FOR INTRACTABLE ITCH IN CHRONIC CHOLESTATIC LIVER DISEASE PATIENTS IS A FEASIBLE, SAFE AND EFFICACIOUS ALTERNATIVE TO LIVER TRANSPLANTATION (2009) (2)
- Class III (morbid) obesity is an independent risk factor for the development of acute on chronic liver failure in patients with decompensated cirrhosis (2018) (2)
- From the Editor's desk....: January 2016. (2016) (2)
- Use of Non-selective Beta blockers in Decompensated Cirrhosis and ACLF (2022) (2)
- Waitlist Priority for Patients with Acute‐on‐Chronic Liver Failure: Not Just Horseplay (2021) (2)
- Erratum to “The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure” [J Hepatol 2015;62:831–840] (2015) (2)
- Faculty Opinions recommendation of Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. (2020) (2)
- Characterization of the protective effects of yaq-001on organ injury in cirrhosis (2018) (2)
- Acute liver failure: updates in pathogenesis and management (2019) (2)
- Validation of the SURFASA score to define steroid responsiveness in patients with acute autoimmune hepatitis. (2021) (2)
- OP16 Evidence for compartmentalised endotoxaemia and its effect on neutrophil function in the portal circulation in cirrhosis (2010) (2)
- P58 Evidence of dendritic cell dysfunction in cirrhosis and its restoration by Toll-like receptor 4 antagonism (2010) (2)
- Impaired central but stimulated humoral regulation of vascular tone in patients with cirrhosis and ascites (1996) (2)
- Rapid detection for infected ascites in cirrhosis using metagenome next‐generation sequencing: A case series (2021) (2)
- Role of renin angiotensin and sympathetic nervous systems in regulation of peripheral vascular tone in patients with refractory ascites. (1998) (2)
- Endotoxemia during liver transplantation (2007) (2)
- Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis ☆ (2021) (2)
- The role of inflammation in hepatic encephalopathy (2006) (1)
- Treatment of hepatic encephalopathy. Authors' reply (2005) (1)
- Reply to "Keep the sick from harm in spontaneous bacterial peritonitis: Dose of beta blockers matters". (2016) (1)
- Forearm blood flow (FBF) responses to exogenous and endogenous sympathetic stimulation in patients with cirrhosis (1998) (1)
- Liver Failure and Intracerebral Hypertension (2005) (1)
- A multi‐journal partnership to highlight joint first‐authors of manuscripts (2015) (1)
- Molecular Adsorbents Recirculating System: Early clinical experience. (2001) (1)
- 169 Kinetics of binding of non-dialysable substances to albumin: relevance in liver disease (2003) (1)
- Gene therapy for Wilson disease : (2015) (1)
- PTU-016 Albumin restores renal blood flow (RBF) autoregulation in patients with refractory ascites and acute-on-chronic liver failure (ACLF) through stabilisation of endothelial function (2012) (1)
- Potential novel approaches to prevent the risk of infection in patients with variceal bleeding. (2021) (1)
- Dimethylarginine (nos inhibitor) levels predict in-patient mortality in alcoholic hepatitis (2005) (1)
- Biological effects of oral nanoporous carbon in bile duct ligated rats (2012) (1)
- PROGNOSTIC INDICATORS OF SHUNT INSUFFICIENCY, VARICEAL REBLEEDING, EARLY MORTALITY AND ENCEPHALOPATHY FOLLOWING TIPSS (1994) (1)
- 652 Remote ischaemic preconditioning of the hind limb improves systemic haemodynamics and reduces reperfusion injury to the liver and lungs (2003) (1)
- PWE-264 Blood lipidomic profiling of hepatocellular carcinoma in human and animal studies identifies lysophosphatidylcholine (24, 0, 0), a discriminatory biomarker (2012) (1)
- DASIMAR: a novel prognostic biomarker for acute cirrhosis decompensation to guide early intervention: a prospective multicenter study (2017) (1)
- 117 GENE DELIVERY OF DIMETHYLARGININE DIMETHYLAMINOHYDROLASE-1 REDUCES PORTAL PRESSURE IN BILE DUCT-LIGATED RATS (2012) (1)
- From the Editor's desk…From the Editor's desk: September 2016. (2016) (1)
- AUTOTAXIN LEVELS MIRROR EFFICACY OF TREATMENT OF CHOLESTATIC PRURITUS (2010) (1)
- P105 ACTIVATION OF SENESCENT GENES IN CHRONIC AND ACUTE-ON-CHRONIC LIVER FAILURE RAT BRAINS (2014) (1)
- Activation of farnesoid X receptor (FXR) by its agonist int-747 restores hepatic endothelial NOS activity and lowers portal pressure in cirrhotic rats by modulating the DDAH-ADMA pathway (2013) (1)
- Reply to: “The quest for the elusive factors that underpin neutrophil dysfunction in cirrhosis goes on” (2012) (1)
- From the editor's desk ... (2015) (1)
- 531 Hepatic inflammation is an important modulator of the circulatory disturbances in cirrhosis (2003) (1)
- P0423 : Role of apoptic DNA and extracellular core histones in inflammasome activation in primary human hepatic stellate cells (2015) (1)
- 189 Hepatic inflammation increases portal pressure through inhibition of eNOS activity — Potential mechanisms (2006) (1)
- O09 A double blind, randomised, placebo-controlled study to assess safety and tolerability of oral enterosorbent Carbalive (Yaq-001) in cirrhotic patients (2021) (1)
- Simulation of a upper gastrointestinal bleed in patients with cirrhosis of the liver: a model to study the metabolism of hepatic encephalopathy (1998) (1)
- Porcine model characterizing various parameters assessing the outcome after acetaminophen intoxication induced acute liver failure (2017) (1)
- Joan Cordoba Cordona (1964-2014): a dedicated clinician, great scientist, mentor, friend, collaborator, critic... (2014) (1)
- Corrigendum to "Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study" [J Hepatol 67 (2017) 940-949]. (2018) (1)
- Editorial: obesity in chronic liver diseases – increased infections; authors' reply (2016) (1)
- Restoration of the defective innate immune system following treatment with the probiotic Lactobacillus casei Shirota in patients with alcoholic cirrhosis: a proof of concept study (2008) (1)
- Management of the critically ill patients with cirrhosis: A multidisciplinary perspective (vol 64, pg 717, 2016) (2016) (1)
- REDUCTION IN HYPERAMMONEMIA WITH L-ORNITHINE PHENYLACETATE (OCR-002) IN BILE-DUCT-LIGATED (BDL) CIRRHOTIC RATS RESTORES BRAIN ENOS ACTIVITY BY MODULATING THE DDAH-ADMA PATHWAY (2009) (1)
- Molecular Adsorbents Recirculating System (MARS) for acute decompensation of chronic liver disease: an early clinical experience (2003) (1)
- P60 Acute lowering of portal pressure in cirrhotic rats by Anti-TNF therapy is associated with reduced NFkB-driven inflammation and improved eNOS function through the asymmetric dimethylarginine-dimethylarginine-diaminohydrolase axis (2010) (1)
- Ammonia Is A Predictor of HE and Mortality In Cirrhosis and Acute On Chronic Liver Failure (ACLF) (2017) (1)
- Interorgan ammonia metabolism in overnight fasted, metabolically stable patients with cirrhosis of the liver (1999) (1)
- Randomized controlled trial of transjugular intra-hepatic portosystemic stent-shunt (TIPSS) versus TIPSS and variceal band ligation (VBL) in the prevention of variceal rebleeding: Final results. (2001) (1)
- Shunt insufficiency after TIPSS (1998) (1)
- Faculty Opinions recommendation of Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia. (2020) (1)
- Faculty Opinions recommendation of Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy. (2020) (1)
- Toll-like receptor 4 inhibition acts synergistically with G-CSF to prevent organ injury and induce liver regeneration in acute-on-chronic liver failure (2020) (1)
- From the Editor’s desk...: January 2018 (2018) (1)
- OP17 Clinical effect of albumin dialysis in patients with intractable pruritus correlates closely with changes in autotaxin activity but not bile salt levels (2010) (1)
- 595 INFLAMMATION UPREGULATES HEPATIC CONNEXIN-43 EXPRESSION IN CIRRHOSIS WHICH DEFINES SUSCEPTIBILITY TO DEVELOPMENT OF ACUTE-ON CHRONIC LIVER FAILURE (2012) (1)
- PMO-123 Gene transfer of dimethylarginine dimethylaminohydrolase-1 reduces portal pressure in a rodent model of cirrhosis (2012) (1)
- Enhanced sensitivity to endothelin-1 in hepatic arteries from patients with cirrhosis. (1999) (1)
- Contribution of angiotensin II (AII) and angiotensin receptor (AT(1)) in the pathogenesis of ascites. (1998) (1)
- P17 TIPS outcomes for Budd–Chiari: a single tertiary centre experience (2011) (1)
- Attitudes toward liver transplantation for ACLF-3 patients determine equity of access. (2022) (1)
- 494 THE BIOMARKER ‘DASIMAR’ (DIMETHYLARGININE SCORE AND ISCHAEMIA MODIFIED ALBUMIN RATIO) IS AN EARLY PREDICTOR OF MORTALITY IN PATIENTS WITH ACUTE LIVER FAILURE (2009) (1)
- Transjugular intrahepatic porto-systemic stent-shunts (TIPSS): Results of long term follow-up of 303 patients. (1998) (1)
- Neurocognitive dysfunction in NAFLD occurs early and is associated with hyperammonemia, neurotransmitter defects, astroglial and microglial activation (2018) (1)
- P57 Administration of branched chain amino acids to hyperammonemic cirrhotic animals is associated with worsening of hyperammonemia and increase in brain oedema (2010) (1)
- Hypothermia for fulminant hepatic failure: A cool approach to a burning problem (2000) (1)
- Evidence for altered renal blood flow autoregulation in cirrhosis. (2003) (1)
- THE ROLE OF DDAH-ADMA IN THE REGULATION OF HEPATIC ENOS ACTIVITY IN ACUTE AND CHRONIC LIVER FAILURE (2008) (1)
- New concepts and perspectives in decompensated cirrhosis. (2021) (1)
- A rise in cerebral blood flow precedes intracranial hypertension in patients with acute liver failure (ALF). (2001) (1)
- Judging the value of ammonia measurement on lactulose dosing: Apples and oranges? (2021) (1)
- 77 EMBOLIZATION OF LARGE SPONTANEOUS PORTOSYSTEMIC SHUNTS FOR REFRACTORY HEPATIC ENCEPHALOPATHY: A EUROPEAN MULTI-CENTER SURVEY ON SAFETY & EFFICACY (2013) (1)
- ROLE OF TOLL-LIKE RECEPTOR-4 IN MEDIATING MULTIORGAN FAILURE IN CIRRHOSIS AS A CONSEQUENCE OF A 2ND HIT (2009) (1)
- LBP-36-Inhibition of glutamine synthetase in monocytes from patients with Acute-on-Chronic Liver Failure resuscitates their antibacterial and inflammatory capacity (2019) (1)
- 250 EVALUATION OF HAEMOSTASIS IN ACUTE LIVER FAILURE: A COMPREHENSIVE STUDY USING TRADITIONAL PLASMATIC TESTS AND WHOLE BLOOD THROMBOELASTOGRAPHY (2012) (1)
- Epigenetic modification of urea cycle enzymes in NAFLD animal models and patients: Implications for novel therapeutic approaches (2018) (1)
- MicroRNA-128 is a Key Regulator of Hepatic Dimethylarginine Dimethylaminohydrolase-1 (DDAH-1) in a Rodent Model of Cirrhosis and Portal Hypertension (2014) (1)
- Effect of TIPSS, terlipressin, anti-TNF and paracentesis on renal blood flow autoregulation: New insight into the pathophysiological basis of renal dysfunction in cirrhosis. (2004) (1)
- Training and Validation of an Artificial Neural Network to predict early mortality in patients undergoing the transjugular intrahepatic portosystemic stent shunt (TIPSS) for variceal haemorrhage: Analysis of data on 398 patients from two centres (1997) (1)
- High prevalence of abnormal alanine and aspartate aminotransferases in a “worried‐well” population in the United Kingdom: Rationale for a liver screening program? (2008) (1)
- Non selective beta-blocker in cirrhosis: not ‘whether’ but ‘who and how’ (2017) (1)
- Systemic inflammation determines ammonia-induced neuropsychological deterioration in cirrhosis. (2004) (1)
- From the Editor's desk...: June 2018. (2018) (1)
- Ammonia: A novel target for the prevention of NAFLD progression in NASH (2018) (1)
- De Novo Generic Tacrolimus in Liver Transplantation (LT) Is Safe and Effective but Results in a Change in Prescribing Behaviour Which May Reduce Cost Savings. (2013) (1)
- A multi-journal partnership to highlight joint first-authors of manuscripts. (2015) (1)
- Altered peripheral vascular responses to vasoactive mediators in patients with pre-ascitic cirrhosis: role of nitric oxide (2001) (1)
- Intrinsic renal disease in cirrhosis: adding insult to injury (2010) (1)
- The Rise of Glutaminase in End-Stage Liver Diseases (2012) (1)
- ADMA correlates with portal pressure in patients with compensated cirrhosis by Vizzutti et al. Eur J Clin Invest 2007; 37: 509–15 (2007) (1)
- Characterization of hepatic encephalopathy (HE) in an acetaminophen (APAP) induced acute liver failure (ALF) mouse model (2005) (1)
- Is there really no life in MARS (2004) (1)
- OC-035 Lifetouch®: A Novel Remote Monitoring Device To Identify Patients With Advanced Cirrhosis Most At Risk Of Decompensation – A Proof Of Concept Study (2014) (1)
- Plasma markers of liver cell death Keratin 18 (K18) and its caspase-cleaved fragment (cK18) are novel biomarkers to define progression of cirrhotic patients with acute decompensation to acute on chronic liver failure (ACLF) and mortality (2016) (1)
- 571 P2X7 RECEPTOR IN ACUTE KIDNEY INJURY OF CIRRHOSIS: A POTENTIAL NOVEL TARGET OF THERAPY (2013) (1)
- High‐risk liver transplant recipients with grade 3 acute on chronic liver failure should receive the good quality graft (2022) (1)
- Presence of multilobular necrosis on liver biopsy identifies corticosteroid responsiveness in acute indeterminate hepatitis (2021) (1)
- Hyperammonemia following a simulated bleed results in neuropsychological deterioration and regional cerebral deactivation. (1999) (1)
- In vivo hepatic phosphorus-31 magnetic resonance spectroscopy after infusion of L-alanine: Understanding the biochemical basis of hepatic decompensation (1996) (1)
- 748 BLOOD LIPIDOMIC PROFILING OF HEPATOCELLULAR CARCINOMA IN HUMAN AND ANIMAL STUDIES IDENTIFIES LYSOPHOSPHATIDYLCHOLINE (24, 0, 0) AS A DISCRIMINATORY BIOMARKER (2012) (1)
- Study of regional neutrophil chemotaxis in chronic liver diseases (CLD) (2001) (1)
- Correction: The role of RIPK1 mediated cell death in acute on chronic liver failure (2022) (1)
- P59 TLR4 antagonist in acute liver failure: a novel therapeutic strategy (2010) (1)
- Hepatic Dimethylarginine Dimethylaminohydrolase-1 (DDAH-1) is Decreased in Acute-on-Chronic Liver Failure due to Post-Transcriptional Regulation by an Altered MicroRNA Profile (2012) (1)
- Vascular hyporesponsiveness in cirrhosis – many facets of a common problem! (2001) (1)
- Occupational hazard in an immunosuppressed patient (2019) (1)
- P1312 : Alfapump system versus transjugular intrahepatic portosystemic shunt and paracentesis in the treatment of ascites. A multicentre randomised controlled study (AGUA-trial) (2015) (1)
- The “Alter Ego” of Albumin in Cirrhosis (2021) (1)
- Diagnosis and management of acute kidney injury in patients with cirrhosis : Revised consensus recommendations of the International Club of Ascites q (2015) (1)
- Pathophysiological basis of clinical changes following treatment with MARS in acute-on-chronic liver failure: A randomized evaluation (2002) (1)
- From the Editor's desk...: August 2016. (2016) (0)
- A More Intensive Regimen of Albumin Dyalisis Improves Survival in Patients with Acute on Chronic Liver Failure. Results from an Individual-Patient Data Meta-Analysis (2016) (0)
- Hypercoagulability progresses to hypocoagulability during evolution of acetaminophen-induced acute liver injury in pigs (2017) (0)
- From the Editor's Desk…: December 2019. (2019) (0)
- From the Editor's desk....: May 2018. (2018) (0)
- 588 ALBUMIN RESTORES RENAL BLOOD FLOW (RBF) AUTOREGULATION IN PATIENTS WITH REFRACTORY ASCITES AND ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) THROUGH STABILIZATION OF ENDOTHELIAL FUNCTION (2012) (0)
- PS-104-Prognosis assessment of acute-on-chronic liver failure in patients with hepatitis B virus-related cirrhosis requires specific criteria (2019) (0)
- Noradrenaline dose levels predicts futility of liver transplantation in patients with paracetamol-overdose related acute liver failure (ALF) (2015) (0)
- Hypothermia may impair hepatic regeneration in acute liver failure - Reply (2005) (0)
- Management of severe ascites: intraperitoneal alfapump versus TIPS (2015) (0)
- From the Editor’s desk...: September 2015 (2015) (0)
- Decompensation of chronic stable alcoholic liver disease by severe exfoliative dermatitis. (2003) (0)
- Pathogenesis of chronic hepatic encephalopathy (CHE): A positron emission tomography (PET) with C-11-Flumazenil and H-1 magnetic resonance spectroscopic (MRS) study (1996) (0)
- Liver transplantation for patients with severe acute on chronic liver failure: it is time to change paradigms. (2023) (0)
- Faculty Opinions recommendation of Causes and consequences of innate immune dysfunction in cirrhosis. (2020) (0)
- FRI-093-Low volume plasma exchange in patients with acute liver failure: A real world study (2019) (0)
- [213] LIPOPOLYSACCHARIDE EXACERBATES BRAIN EDEMA AND PRODUCES COMA IN CIRRHOTIC RATS THROUGH A CYTOTOXIC MECHANISM: AN ELECTRON-MICROSCOPIC STUDY (2007) (0)
- P32 Gut sterilisation with norfloxacin modulates cerebral inflammation in cirrhosis and prevents deterioration in brain oedema and delays coma in cirrhotic rats (2010) (0)
- From the Editor's desk....: April 2017. (2017) (0)
- From the Editor's desk...: August 2017. (2017) (0)
- Contents (2020) (0)
- From the Editor's desk...: June 2016. (2016) (0)
- From the Editor's desk...: September 2017. (2017) (0)
- P30 Cytoplasmic expression of Toll-like receptor-9 is associated with increased cellular proliferation in hepatocellular carcinoma (2010) (0)
- The kynurenine pathway in cirrhosis. Relationship with the development of acute decompensation and acute-on-chronic liver failure, clinical course and mortality (2018) (0)
- Temporary Liver Support : Current Concepts (2009) (0)
- Ornithine Phenylacetate: A Novel Strategy for the Treatment of Hepatic Encephalopathy (2012) (0)
- Cirrhosis and acute on chronic liver failure: is ammonia a predictor of hepatic encephalopathy and mortality? (2017) (0)
- 771 EVIDENCE OF SEVERE NEUTROPHIL DYSFUNCTION IN STABLE CIRRHOSIS USING A NOVEL IN VIVO MODEL OF INFLAMMATION (2009) (0)
- Big Title: Gut-Liver interaction in PSC Small titles: Sarcopenia and fibrosis in NAFLD Trends in global HBV epidemiology Dynamics of HCV replication organelles generation ACUTE LIVER INJURY (2017) (0)
- Novel ALFA-pump treatment for refractory ascites: the evolving role of the urologist (2013) (0)
- Enhanced renal ammonia excretion following volume expansion is mediated through the renin-angiotensin system (2001) (0)
- PWE-098 Increase in gut permeability is an early event in cirrhosis and is not associated with bacterial translocation, systemic inflammation or clinical features: a prospective longitudinal study (2015) (0)
- PTU-049 Modulation of toll-like receptor genes with selective gut decontamination in cirrhotic animals prevents the development of acute-on chronic liver failure (ACLF) (2012) (0)
- Efficiency of parallel stent placement for the treatment of transjugular intrahepatic portosystemic stent shunt (TIPSS) insufficiency (1998) (0)
- 523 HEMODYNAMIC EFFECTS OF TEZOSENTAN, A DUAL ENDOTHELIN RECEPTOR ANTAGONIST, IN PATIENTS WITH CIRRHOSIS (2010) (0)
- Faculty Opinions recommendation of Sildenafil reduces neuroinflammation in cerebellum, restores GABAergic tone, and improves motor in-coordination in rats with hepatic encephalopathy. (2020) (0)
- Defining the Prognosis of Critically Ill Patients with Alcohol-Related Liver Disease. (2021) (0)
- Decreased circulating arginine in ALF mice does not compromise whole body NO production (2006) (0)
- In Patients With Acute Liver Failure Requiring Hemofiltration, Increased Systemic Inflammation And Endothelial Activation Is Associated With Prothrombotic Potential Evidenced By Thrombosed Hemofiltration Circuits (2012) (0)
- Biomarkers to assess liver function. (2007) (0)
- Hepatic sinusoidal dysfunction following liver transplantation and the role of cGMP (1996) (0)
- Hepatic inflammation is an important determinant of portal pressure in alcoholic liver disease (2003) (0)
- Short article: Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis (2017) (0)
- Treatment With Tlr 4 Antagonist Restores the Inflammatory Cellular Immune Dysfunction in Acetaminophen (Apap) Induced Acute Liver Failure (Alf) Mice (2010) (0)
- From the Editor’s desk…: May 2015 (2015) (0)
- P33 Treatment with Toll-like receptor 4 antagonist restores the inflammatory cellular immune dysfunction in acetaminophen induced acute liver failure mice (2010) (0)
- P949 QUANTITATION AND LOCATION OF THE SEVERITY OF BRAIN EDEMA IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE AND HEPATIC ENCEPHALOPATHY (2014) (0)
- Inflammation significantly exacerbates the effect of hyperammonemia on neurological function in cirrhosis (2003) (0)
- From the Editor's desk...: May 2017. (2017) (0)
- A new model for identification of HBV-related pre-ACLF (2022) (0)
- From the Editor's desk...: March 2018. (2018) (0)
- PWE-099 Porto-systemic shunt embolization and recurrent ascites: a single centre case series (2015) (0)
- Transhepatic neutrophil chemotaxis and chemokine concentrations in patients with chronic liver disease. (2001) (0)
- Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis (2011) (0)
- Acute Lowering of Portal Pressure in Cirrhotic Rats by Anti-TNF Therapy is Associated with Reduced Inflammation and Improved eNOS Function Through the ADMA-DDAH Axis (2015) (0)
- Stratification based on acute on chronic liver failure (ACLF) has greater prognostic accuracy than stratification based on creatinine, Acute Kidney Injury (AKI), Encephalopathy or Child-Pugh score. Pognostic relevance of 48 hour post-enrolment ACLF stratification (2013) (0)
- Wide variations in liver transplantation (LT) policies across Europe for patients with acute-on-chronic liver failure (ACLF) despite excellent post-LT survival: Results of a CLIF/ELITA collaborative study (2020) (0)
- Editorial Improving Survival in Patients with Decompensated Cirrhosis (2011) (0)
- P37 Development of a Stable, Clinically Relevant, Fully Monitored and Managed Reproducible Model of Paracetamol Induced Acute Liver Failure in the Pig (2010) (0)
- From the Editor's desk…: August 2019. (2019) (0)
- Cognitive dysfunction occurs early in experimentally induced NAFLD and is associated with systemic inflammation (2020) (0)
- Compositions with ornithine and phenylacetate and phenylbutyrate for treatment of hepatic encephalopathy (2005) (0)
- Prolonged intensive care support of patients with acute on chronic liver failure and CLIF-C ACLF score greater than 70 may be futile (2017) (0)
- The degree of disturbance of renal blood flow autoregulation in cirrhosis determines the severity of renal dysfunction (2007) (0)
- The novel gene nostrin and a splice-variant are highly expressed in alcoholic hepatitis and may explain increased intra-hepatic resistance despite normal eNOS expression (2004) (0)
- Double blind randomised study of effect of simulated bleeding onneutrophil chemotaxis in patients with cirrhosis (2000) (0)
- From the Editor’s desk...: July 2015 (2015) (0)
- EASL Recognition Award Recipient 2020: Prof. Roger Williams. (2020) (0)
- Preliminary results of in vitro (H-1) magnetic resonance spectroscopy of the plasma in patients with cirrhosis and chronic hepatic encephalopathy. (1997) (0)
- Recovery of severe critically ill Acute Liver Failure (ALF) patients is associated with significantly better survival than patients undergoing liver transplantation (2015) (0)
- Corrigendum to "From the Editor's Desk August 2018" [J Hepatol 69 (2018) 265-268]. (2018) (0)
- Abstracts (2000) (0)
- 953 EARLY LIVER BIOPSY IS CRUCIAL FOR ACCURATE DIAGNOSIS OF ALCOHOLIC HEPATITIS AND PROVIDES INDEPENDENT PROGNOSTIC INFORMATION IN PATIENTS WITH DECOMPENSATED ALCOHOLIC LIVER DISEASE (2008) (0)
- P: 13 The Role of Monocarboxylate Transporter-1 and Lactate Metabolism on the Development of Cognitive Deficits During NAFLD (2019) (0)
- Impaired Cerebral Oxygenation, But Preserved Cerebrovascular Reactivity, In An Animal Model of Hepatic Encephalopathy (2017) (0)
- Hepatic Encephalopathy . A 2016 perspective (2016) (0)
- Variceal band ligation and infection. (1993) (0)
- From the Editor's desk...: April 2016. (2016) (0)
- From the Editor's desk…: May 2019. (2019) (0)
- 680 URINARY TLR4: A NOVEL BIOMARKER TO IDENTIFY PATIENTS WITH ACUTE KIDNEY INJURY IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE (2012) (0)
- Not all mice are the same: Standardization of animal research data presentation. (2016) (0)
- Amino acids and ammonia in liver disease (2003) (0)
- The Mortality of Acute-on-Chronic Liver Failure by APASL vs. EASL-CLIF definition: A Multicenter, Retro- spective Cohort Study in Korea (KACLiF Study) (2014) (0)
- OC-023 Extracorporeal liver support using UCL-arsenel reduces inflammation, improves haemodynamic function and increase survival time in a porcine paracetamol-induced acute liver failure model (2012) (0)
- Faculty Opinions recommendation of L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. (2020) (0)
- ‘Hepatology’ on the move (2014) (0)
- Mellanby, R. J. (2014). Hyperammonemia and Systemic Inflammatory Response Syndrome Predicts Presence of Hepatic Encephalopathy in Dogs (2013) (0)
- P0185 : Acute-on-Chronic Liver Failure not associated with bacterial infections. Characteristics, prognosis and importance of systemic inflammatory response (2015) (0)
- Soluble immune checkpoints are involved in the immunopathogenesis of ACLF (2020) (0)
- Long-term outcomes of patients undergoing liver transplantation for acute-on-chronic liver failure Authors (2020) (0)
- P28 EVIDENCE FOR INTRACELLULAR IMMUNOMODULATORY AND ANTIOXIDANT ACTION OF ALBUMIN TO PROVIDE ENDOTHELIAL PROTECTION IN LIVER FAILURE (2014) (0)
- Reply to 'Ammonia and prognosis of cirrhosis: a new perspective for identifying high risk patients'. (2022) (0)
- DEVELOPMENT OF A STABLE, CLINICALLY RELEVANT, FULLY MONITORED AND MANAGED, REPRODUCIBLE MODEL OF ACETAMINOPHEN (APAP) INDUCED ACUTE LIVER FAILURE (ALF) IN THE PIG (2010) (0)
- Hepatic and Renal expression of the ammonia transporter Rhesus protein (Rhcg) plays a critical role in modulating hyperammonemia and hepatic encephalopathy in liver failure (2014) (0)
- Systemic delivery of gene therapy – a proof of concept study in a model of cirrhosis and portal hypertension (2017) (0)
- 10 years follow-up of 484 patients with transjugular intra-hepatic portosystemic stent-shunt (TIPSS). (2001) (0)
- Human Serum Albumin administration prevents cell death-derived extracellular nucleosomes and core-histones-driven inflammasome activation and portal hypertension in Acute on Chronic Liver Failure (2017) (0)
- Recombinant glutamine synthetase (AM-535): a novel therapeutic approach for the treatment of hyperammonaemia and its deleterious effects on multiple systems (2020) (0)
- Cellular Neutrophil Dysfunction is a Feature of Early Cirrhosis and Associated with an Increased Risk of Decompensation and Bacterial Infection (2016) (0)
- THERAPEUTIC APPROACHES IN HE BASED ON PATHOGENETIC FACTORS (2009) (0)
- HEPATIC ENCEPHALOPATHY : A PARADIGM SHIFT (2013) (0)
- Corrigendum: Lipopolysaccharide-Induced Neutrophil Dysfunction Following Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Insertion is Associated with Organ Failure and Mortality (2017) (0)
- Towards goal-directed therapy of hepatorenal syndrome: we have the tools but we need the trials (2008) (0)
- F.N.18 NEUTROPHIL PHAGOCYTIC DYSFUNCTION IN STABLE CIRRHOSIS IS INDEPENDENT OF BACTERIAL DNA AND ASSOCIATED WITH INCREASED EXPRESSION OF TLR-4 (2010) (0)
- From the Editor's Desk…: November 2019. (2019) (0)
- Soluble CD163, a Marker of Macrophage Activation, is Increased in Early Allograft Dysfunction after Liver Transplantation (2016) (0)
- From the Editor's desk...: June 2017. (2017) (0)
- Endothelial injury following liver graft reperfusion, and the role of neutrophils. (1996) (0)
- PTU-090 Circulating Level of End Product of Apoptosis Caspase-Cleaved Keratin 18 Reflects Clinical Severity in Acute on Chronic Liver Disease and Is A Potential Biomarker for Diagnosis and Therapeutic Monitoring (2016) (0)
- Non-selective beta blockers in cirrhosis: time to extend the indications? (2019) (0)
- THU-050-Genetic variants of innate immunity receptors are associated with mortality but not with bacterial infections in liver cirrhosis (2019) (0)
- Hepatic encephalopathy. (2022) (0)
- 91 TOLL LIKE RECEPTOR 4 ANTAGONIST PREVENTS ACETAMINOPHEN INDUCED ACUTE LIVER FAILURE IN MICE: A NOVEL THERAPEUTIC STRATEGY (2012) (0)
- PWE-265 Plasma metabolite profiling in a rat model of hepatocellular carcinoma and the effects of co-administered antibiotics (2012) (0)
- Hyporesponsiveness to endothelin-1 in patients with well compensated cirrhosis is mediated through ETB receptors. (1999) (0)
- Faculty Opinions recommendation of Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial. (2020) (0)
- Reply to 'The possible link between higher ammonia levels associated with non-alcoholic fatty liver related cirrhosis and diabetes: are we missing chronic kidney disease?' (2022) (0)
- Oxygen consumption and mitochondrial function by the brain is severely perturbed during the early phase of liver failure. (2004) (0)
- OP21 The role of Toll like receptor-4 in the pathogenesis of hepatorenal syndrome in a Bile duct ligated model of cirrhosis in the rat (2010) (0)
- Hyperammonaemia is an independent biomarker of liver-related complications and mortality in clinically stable outpatients with cirrhosis (2022) (0)
- Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acutely decompensated cirrhosis. (2022) (0)
- From the Editor's Desk…: October 2018. (2018) (0)
- Selected Commentary to: "Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study" (2005) (0)
- 597 PERICYTE ACTIVATION AND CEREBRAL SEQULAE OF CIRRHOSIS (2012) (0)
- Chloroquine: A novel strategy for the prevention of Hepatocellular carcinoma (2012) (0)
- Reply (2019) (0)
- Reply to: "Non-selective beta-blockers for the patients with acute on chronic liver failure". (2016) (0)
- Basal hyperactivity of neutrophil oxidative burst in chronic liver disease (2002) (0)
- The cost of variceal bleeding in cirrhosis: A pharmacoeconomic model of the UK variceal haemorrhage guidelines (2003) (0)
- Moderate hy p o t h e rmia for uncontrolled intracranial hy p e rt e n s i o n i n acute liver failure (1999) (0)
- From the Editor's desk...: November 2016. (2016) (0)
- Faculty Opinions recommendation of O-GlcNAcylation-dependent upregulation of HO1 triggers ammonia-induced oxidative stress and senescence in hepatic encephalopathy. (2020) (0)
- Corrigendum to "Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension" [J Hepatol 62 (2015) 325-331]. (2017) (0)
- HYPONATREMIA WORSENS NEUROPSYCHOLOGICAL EFFECT OF 'INDUCED HYPERAMMONEMIA' DUE TO REDUCED BRAIN BUFFERING CAPACITY (2008) (0)
- Vaccination in liver diseases and liver Transplantation: Recommendations, implications and opportunities in the post-covid era (2023) (0)
- CLIF-OF and CLIF-ACLF are better than King’s College Hospital criteria in predicting mortality in patients with Acute Liver Failure: a retrospective single centre study (2015) (0)
- P36 ADMINISTRATION OF RECOMBINANT ALKALINE PHOSPHATASE PREVENTS DEVELOPMENT OF ACUTE ON CHRONIC LIVER FAILURE (ACLF) IN A RODENT BILE-DUCT LIGATION MODEL (2014) (0)
- Hepatic Encephalopathy: Pathogenesis, Diagnosis and Management (1998) (0)
- PTU-010 Computational model predicts that portosystemic shunting is key to the development of hyperammonaemia in liver cirrhosis (2012) (0)
- Neutrophil Dysfunction Patterns in Early Cirrhosis could be used to Help Identify Patients with Hepatic Encephalopathy (2017) (0)
- The brain in acute on chronic liver failure (2014) (0)
- Remote ischaemic preconditioning of the hind limb reduces the local and systemic adverse effects of reperfusion injury following total liver ischaemia (2004) (0)
- 2 0 ,7 0 -Dichlorofluorescein is not a probe for the detection of reactive oxygen and nitrogen species (2012) (0)
- Share MELD-35 does not fully address the high waiting list mortality of patients with acute on chronic liver failure grade 3 (2020) (0)
- NAFLD-induced encephalopathy is associated with low-grade brain tissue hypoxia and inflammation, as well as cerebrovascular, glial, metabolic and behavioural alterations (2022) (0)
- OP08 Evidence for early astrocyte activation, cellular stress and compensatory microglial related transforming growth factor-α responses in bile-duct ligated rats (2010) (0)
- Should a biopsy precede liver resection or transplantation for presumed HCC when the AFP is normal (2004) (0)
- P: 18 Impaired Cerebral Oxygenation, but Preserved Cerebrovascular reactivity, in an Animal Model of Hepatic Encephalopathy (2019) (0)
- From the Editor's desk...: November 2017. (2017) (0)
- Neurobehavioral disturbances and hyperammonemia are evident in rodent model of NAFLD prior to cirrhosis stages (2017) (0)
- Management problems in liver diseaseAcute liver failure (2015) (0)
- Letter to the editor: The role of acute‐on‐chronic liver failure in predicting recovery in severe alcoholic hepatitis (2022) (0)
- Improvement in portal and regional haemodynamics following anti-TNF therapy in alcoholic hepatitis (2003) (0)
- TARGETING TLR7 AND 9: A NOVEL STRATEGY FOR TREATMENT OF CHOLANGIOCARCINOMA (2013) (0)
- From the Editor's desk...: May 2017. (2017) (0)
- Lactate, and Intracranial Pressure in Pigs with Acute Liver Failure (2007) (0)
- PMO-092 TLR7 expression is increased in hepatocellular cancer (HCC) and its modulation is associated with alterations in tumour growth: a novel therapeutic target (2012) (0)
- From the Editor's desk....: August 2018. (2018) (0)
- haemorrhage in cirrhotic patients UK guidelines on the management of variceal (2005) (0)
- FRI-308-Inhibition of alpha 2A adrenergic receptors reduces liver inflammation in experimental NASH (2019) (0)
- SAT-056-Development of a novel prognostic model for cirrhotic patients with difficult-to-treat ascites and low MELD scores (2019) (0)
- P39 EVIDENCE THAT AMMONIA ACTS AS A DANGER ASSOCIATED MOLECULAR PATTERN (DAMP) AND SIGNALS THROUGH THE TOLL-LIKE RECEPTOR-4 (TLR4) PATHWAY (2014) (0)
- Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis. (2017) (0)
- Hepatocytes undergo pyroptosis in response to lipopolysaccharide exposure, and can be sensitised to cell death by ER stress (2020) (0)
- Probiotics for patients with liver cirrhosis: Reply (2008) (0)
- Treatment of shunt insufficiency after TIPSS by balloon angioplasty and insertion of a parallel shunt. (1997) (0)
- The physical component of the SF-36 Quality of Life tool is an independent predictor of mortality in patients with severe ascites (2018) (0)
- From the Editor's desk....: September 2018. (2018) (0)
- Moderate hypothermia abolishes neutrophil oxidative burst induced by hyperammonemia but phagocytosis is unaffected (2005) (0)
- Table of contents (2016) (0)
- YPOTHERMIA IN A CUTE L IVER F AILURE (2013) (0)
- Role of Ammonia in NAFLD: An Unusual Suspect (2023) (0)
- P094 Potential mechanisms underlying the protective effect of long-term albumin infusion in cirrhosis (2021) (0)
- THU-060 – Brain glymphatic clearance is impaired in a rat model of cirrhosis (2017) (0)
- Increased cerebral and peripheral vasodilation following TIPSS is due to increased whole body nitric oxide (NO) production. (2002) (0)
- Editorial: proton pump inhibitor therapy and liver disease progression—more cause for concern? (2018) (0)
- P093 Toll-like receptor 4 inhibition acts synergistically with G-CSF to prevent organ injury and induce liver regeneration in acute-on-chronic liver failure (2021) (0)
- Development and validation of the CLIF-AD score for the prognosis of patients with acute decompensation of cirrhosis not fulfilling criteria for acute-on-chronic liver failure (ACLF) (2014) (0)
- PRO: Patients With Acute‐on‐Chronic Liver Failure Should Receive Priority on the Liver Transplant Waiting List (2022) (0)
- Haemostasis is patients with acute kidney injury due to acute liver failure (2013) (0)
- Reply to letter Ref: JHEPAT-D-16-00820 by Ustungad et al. Non selective beta-blockers in ACLF (reply) (2016) (0)
- Authors' reply to: G-CSF exacerbates liver injury in a mouse model of autoimmune hepatitis. (2023) (0)
- Journal of Hepatology, 2016. (2016) (0)
- Remote ischaemic preconditioning of the hind limb improves systemic haemodynamics and reduces reperfusion injury to the liver and lung (2003) (0)
- OC-068 Albumin is central in mediating the cardio-renal dysfunction of cirrhosis: a study in analbuminaemic rats (2012) (0)
- From the Editor's desk...: February 2016. (2016) (0)
- The cost of variceal bleeding in cirrhosis - A comparison of a decision based economic model and patient data (2005) (0)
- Kidney inflammation Kidney function Kidney fibrosis Kidney inflammation Kidney function Kidney fibrosis Common bile duct ligation (2017) (0)
- MELD remains the best predictor of mortality in outpatients with cirrhosis, severe ascites, and MELD score ≤ 18 (2020) (0)
- O089 : Increased neuronal expression of K-type glutaminase potentiates brain edema in acute liver failure mice through a TLR4 dependent pathway (2015) (0)
- Terlipressin for hepatorenal syndrome: opportunities and challenges. (2023) (0)
- Reply to: "Does ammonia really disrupt brain oxygen homeostasis?" (2022) (0)
- From the Editor's Desk: September 2019. (2019) (0)
- Hepatic Encephalopathy after TIPSS (1997) (0)
- From the Editor's desk…: July 2019. (2019) (0)
- A SSOCIATION OF REDUCED EXTRACELLULAR BRAIN AMMONIA , LACTATE , AND INTRACRANIAL PRESSURE IN PIGS WITH ACUTE LIVER FAILURE (2015) (0)
- SIRS, Bacterial Infections, and Alterations of the Immune System (2011) (0)
- Hyperammonaemia defines the risk of acute-on-chronic liver failure in clinically stable outpatients with cirrhosis (2022) (0)
- GRAFT FUNCTION FOLLOWING LIVER-TRANSPLANTATION IS DETERMINED BY THE DEGREE OF REPERFUSION INJURY AND IS PREDICTED EARLY BY INDOCYANINE GREEN CLEARANCE (1995) (0)
- From the Editor's Desk…: October 2018. (2018) (0)
- 238 EXTRACORPOREAL LIVER SUPPORT USING UCL-ARSENEL REDUCES INFLAMMATION, IMPROVES HAEMODYNAMIC FUNCTION AND INCREASE SURVIVAL TIME IN A PORCINE PARACETAMOL-INDUCED ACUTE LIVER FAILURE MODEL (2012) (0)
- PTU-030 Selective gut decomtamination reduces hepatic expression of toll-like receptor (TLR) 4 and development of cirrhosis but does not prevent development of hepatocellular carcinoma (HCC) (2012) (0)
- P51 Inadequate compensation by glutamine synthetase and increased glutaminase activity contributes to hyperammonaemia in cirrhosis (2010) (0)
- Reply to Dr Larsen (1998) (0)
- P0105 : Changes in the CNS connexin 43 expression and function in the pathogenesis of hepatic encephalopathy (2015) (0)
- Acute Liver Failure-Organ Failure (ALF-OF) score is better than King’s College Hospital criteria in predicting mortality in patients with non-paracetamol-related acute liver failure (ALF) (2018) (0)
- It is justified to biopsy presumed hepatocellular carcinoma (HCC) when the alfa fetoprotein (AFP) is normal. (2001) (0)
- 578 ALBUMIN INFUSION IMPROVES SYSTEMIC AND RENAL BLOOD FLOW AUTOREGULATION BY RESTORATION OF ENDOTHELIAL DYSFUNCTION (2013) (0)
- PWE-115 Acute decompensation of cirrhosis requiring hospitalisation is not reversible and defines future organ specific decompensation (2015) (0)
- Impact of receptor interacting protein kinase 3 levels on acute on chronic liver failure progression (2018) (0)
- Treatment of hepatic encephalopathy (2005) (0)
- From the Editor's desk....: April 2018. (2018) (0)
- From the Editor's desk…: June 2019. (2019) (0)
- Acute-On-Chronic Liver Failure: Applying the PIRO Concept (2013) (0)
- Embolization of large portosystemic shunts for refractory hepatic encephalopathy: a european survey (2013) (0)
- From the Editor's desk.…: December 2018. (2018) (0)
- Worsening of cerebral hyperaemia in acute liver failure (ALF) with terlipressin (2003) (0)
- Treatment of hepatic encephalopathy - Reply (2005) (0)
- Combined Hepatic Artery and Segmental Portal Vein Occlusion in Antiphospholipid Syndrome (2000) (0)
- From the Editor’s desk...: June 2015 (2015) (0)
- 534 MUSCLE GLUTAMINE SYNTHASE REGULATES THE SEVERITY OF HYPERAMMONEMIA, HEPATIC INFLAMMATION, BRAIN SWELLING AND SURVIVAL IN ACETAMINOPHEN HEPATOTOXICITY (2013) (0)
- LONGITUDINAL STUDIES OF COAGULATION PROFILE IN THE SYSTEMIC AND PORTAL CIRCULATIONS IN A PORCINE MODEL OF ACETAMINOPHEN INDUCED ACUTE LIVER FAILURE SHOW THAT A HYPERCOAGUABLE STATE PRECEDES A HYPOCOAGUABLE STATE AND IS ASSOCIATED WITH ENDOTOXAEMIA (2013) (0)
- P0443 : Hyperammonemia activates human hepatic stellate cells and is a target for treatment of portal hypertension (2015) (0)
- Refining the renal failure criteria of the EASL-CLIF diagnostic model for defining acute-on-chronic liver failure (ACLF) (2020) (0)
- Dogs with congenital porto-systemic shunting (cPSS) and hepatic encephalopathy have higher serum concentrations of C-reactive protein than asymptomatic dogs with cPSS (2012) (0)
- ROLE OF AQUAPORIN 4 AND MAPK INTRACELLULAR SIGNALLING PATHWAYS IN THE DEVELOPMENT OF HYPERAMMONEMIC CEREBRAL EDEMA (2008) (0)
- Muscle Glutamine Synthetase Plays a Critical Role in Ammonia Homeostasis in Acute Liver Failure (2012) (0)
- H EPATIC ENCEPHALOPATHY : N OVEL INSIGHTS INTO CLASSIFICATION , PATHOPHYSIOLOGY AND THERAPY . (2020) (0)
- 193 Aseptic inflammation independent of its source is important in the development of advanced grades of encephalopathy in alcoholic cirrhosis (2004) (0)
- Therapy for Primary Prophylaxis of Varices: And, the Winner Is ... ? (2003) (0)
- Addition of vasoactive drug therapy improved the effectiveness of injection sclerosis or band ligation for acute variceal bleeding but failed to produce a significant reduction in mortality (2002) (0)
- Wall or Palmaz stents for TIPSS (1994) (0)
- Thalidomide : an old drug for a new indication ? (2016) (0)
- NON-ALCOHOLIC FATTY LIVER DISEASE ( NAFLD ) NGAL as an inflammatory mediator , preserved hemostatic status in NAFLD (2016) (0)
- Losartan and renal sodium handling (2000) (0)
- Ammonia metabolism in cirrhotic patients with TIPS. Authors' reply (2003) (0)
- Role of Toll-Like Receptor 4 in Modulating the Brain-Gut Axis in the Pathogenesis of Hepatic Encephalopathy (2016) (0)
- Causes of variability in listing and access to liver transplantation for critically ill patients with cirrhosis: Acknowledging the elephant in the room (2022) (0)
- British Association for the Study of the Liver Meeting (2000) (0)
- Prevention of infection in patients with cirrhosis with probiotic Lactobacillus casei Shirota (2019) (0)
- PWE-094 Monitoring heart rate variability during acute decompensation predicts mortality and risk of recurrent hospitalisation (2015) (0)
- From the Editor's desk....: March 2019. (2019) (0)
- Oral administration of nanoporous carbons reduce severity of non-alcoholic steatohepatitis by modulating hepatic kupffer cell function: a novel therapeutic approach (2012) (0)
- Severe Acute Hepatic Encephalopathy in Cirrhotic patients : The gut remains an important target of therapy (2015) (0)
- Combinations of inflammatory markers, soluble (s)CD163, mannose receptor (sMR) and neutrophil gelatinase associated lipocalin (NGAL), predicts mortality in patients with acute-on-chronic liver failure (2018) (0)
- Acute-on-Chronic Liver Failure in Patients with Alcoholic Liver Disease (2019) (0)
- From the Editor's desk... (2017) (0)
- Role of Toll-like receptor 4 (TLR4) in regulating severity of hyperammonemia and gene expression of urea cycle enzymes (2018) (0)
- P.157 “OUT-PATIENT” ALBUMIN DIALYSIS FOR INTRACTABLE ITCH IN CHRONIC CHOLESTATIC LIVER DISEASE IS AN ALTERNATIVE TO LIVER TRANSPLANTATION (2010) (0)
- Tipps The Edinburgh experience Long term follow-up (1994) (0)
- O70 LIFETOUCH: A NOVEL REMOTE MONITORING DEVICE TO IDENTIFY PATIENTS WITH ADVANCED CIRRHOSIS MOST AT RISK OF DECOMPENSATION – A PROOF OF CONCEPT STUDY (2014) (0)
- Faculty Opinions recommendation of Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy. (2020) (0)
- Faculty Opinions recommendation of Role of peripheral inflammation in hepatic encephalopathy. (2020) (0)
- Editorial: infections and hepatic encephalopathy—does the chicken or the egg come first? A novel perspective at the horizon. Authors’ reply (2022) (0)
- Post-Transcriptional Regulation of Hepatic DDAH1 with TNF Blockade Leads to Improved eNOS Function and Reduced Portal Pressure In Cirrhotic Rats (2017) (0)
- Increased phosphate-activated glutaminase activity contributes substantially to the hyperammonemia in acute liver failure. (2004) (0)
- Letter to the Editors (2005) (0)
- COMPOSITIONS COMPRISING ornithine and phenylacetate phenylbutyrate OR TREATMENT hepatic encephalopathy (2005) (0)
- An exciting time for Hepatology (2013) (0)
- Stumbling into encephalopathy: chest trauma in a patient with alcoholic cirrhosis. (2011) (0)
- O016 SHORT CHAIN FATTY ACID INTERORGAN EXCHANGE IN PATIENTS WITH HEPATIC FAILURE (2008) (0)
- 586 RENAL NKCC2 TRANSPORTER TRIGGERS ENHANCED URINARY AMMONIA EXCRETION DURING INDUCED HYPERAMMONEMIA: A NOVEL TARGET OF THERAPY FOR HEPATIC ENCEPHALOPATHY? (2012) (0)
- Alterations in the CNS Hemichannel Function and Neurochemical Phenotype in the Pathogenesis of Hepatic Encephalopathy (2016) (0)
- Faculty Opinions recommendation of Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis. (2020) (0)
- 809 Improvement in cerebral lactate, glutamate and energy metabolism with albumin dialysis in a large animal model of acute liver failure: a microdialysis study (2003) (0)
- Ammonia Produces Pathological Changes And Activation In Human Hepatic Stellate Cells And Is A Target For Therapy In Portal Hypertension (2015) (0)
- FRI-084-Targeting Toll-Like Receptor 4 signalling with TAK-242: A novel therapy for acute liver failure (2019) (0)
- P1342 : Prospective real world outcomes study of he patients’ experience on rifaximin-α (PROSPER): An observational study among 550 patients (2015) (0)
- Impaired brain glymphatic flow in a rodent model of chronic liver disease and minimal hepatic encephalopathy (2017) (0)
- Hepatocyte apoptosis: An important mechanism of cell-death in patients with acute on chronic liver failure (ACLF)? (2013) (0)
- From the Editor's desk....: July 2018. (2018) (0)
- 791 Contractile response of femoral arteries in pigs with acute liver failure (2003) (0)
- Inflammation significantly exacerbates the effect of hyperammonemia on neurological function in chronic liver disease. (2002) (0)
- Benzodiazepine receptor density is globally upregulated in chronic hepatic encephalopathy (CHE): A positron emission tomography (PET) study with C-11-flumazenil (1997) (0)
- P0151 : Covert hepatic encephalopathy comprises two clinically and pathophysiologically distinct syndromes: A prospective longitudinal study (2015) (0)
- MODULATION OF TOLL-LIKE RECEPTOR GENES WITH SELECTIVE GUT DECONTAMINATION IN CIRRHOTIC ANIMALS PREVENTS THE DEVELOPMENT OF ACUTE-ON CHRONIC LIVER FAILURE (ACLF) (2012) (0)
- P: 44 Non-canonical Inflammasome as a Driver of Hepatic Encephalopathy in a Mouse Model of Acute-on-Chronic Liver Failure (2019) (0)
- 293 SELECTIVE GUT DECOMTAMINATION REDUCES HEPATIC EXPRESSION OF TOLL-LIKE RECEPTOR (TLR) 4 AND DEVELOPMENT OF CIRRHOSIS BUT DOES NOT PREVENT DEVELOPMENT OF HEPATOCELLULAR CARCINOMA (HCC) (2012) (0)
- From the Editor's desk...: October 2016. (2016) (0)
- Treatment with the Adra2a antagonist, Yohimbine, reduces fibrosis progression and liver inflammation in a NASH fibrosis rat (2018) (0)
- Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with ACLF across Europe (2018) (0)
- 620 IMMUNOHISTOCHEMICAL CHARACTERIZATION OF ASTROGLIAL IMMUNE RESPONSES IN CIRRHOTIC RATS (2011) (0)
- P: 35 Hepatic Encephalopathy Is an Independent Risk Factor for the Occurrence of Infection in Cirrhotic Patients With Acute Decompensation (2019) (0)
- From the Editor's Desk…: November 2019. (2019) (0)
- Assessment and Management of the Liver Transplant Candidate with Acute‐on‐Chronic Liver Failure (2021) (0)
- P098 CirrhoCare®-a pilot study of digital home management of advanced cirrhosis to determine feasibility and utility to diagnose new decompensation events (2021) (0)
- Ammonia elevates B-neurexin in hepatic stellate cells to escape NK cells activity (2017) (0)
- 154 THE CONTRIBUTIONS OF DE NOVO ARGININE GENERATION AND ARGINASE ACTIVITY TO WHOLE BODY ARGININE METABOLISM IN ACUTE LIVER FAILURE (2009) (0)
- Corrigendum to "Impaired brain glymphatic flow in experimental hepatic encephalopathy" [J Hepatol 69 (2019) 40-49]. (2019) (0)
- Author and Subject Index Proceedings (2002) (0)
- Corrigendum to 'Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study' [J Hepatol 67 (2017) 940-949]. (2018) (0)
- `Nipped in the Budd’: hepatic venous outflow obstruction in evolution (2005) (0)
- Considering a NEW "Trojan Horse" hypothesis in Brain Edema of Acute Liver Failure: K Glutaminase is exclusively neuronal (2012) (0)
- Long-term albumin administration improves survival, reduces TLR4 mediated hepatic inflammation and reduces gut translocation in models of cirrhosis (2022) (0)
- Box 1 Goals of therapy with liver support devices Primary goal c In acute liver failure : recovery of patient to normal health c In acute on chronic liver failure : recovery to the state before decompensation (2004) (0)
- Hepatic Encephalopathy: A multiorgan perspective. (2003) (0)
- FRI-115-Toll-like receptor 4: A novel therapeutic target for the treatment of hyperammonemia (2019) (0)
- From the Editor's desk...: October 2017. (2017) (0)
- OC-066 Toll like receptor 4 antagonist prevents acetaminophen induced acute liver failure in mice: a novel therapeutic strategy (2012) (0)
- P0180 : Increase in gut permeability is an early event in cirrhosis and is not associated with bacterial translocation, systemic inflammation or clinical features: a prospective longitudinal study (2015) (0)
- INCREASE IN PLASMA MICRORNA POOL AND GENOMIC DNA LEVELS IN AN ACETAMINOPHEN-INDUCED PORCINE MODEL OF ACUTE LIVER FAILURE: A KINETIC STUDY (2013) (0)
- From the Editor's Desk: January 2019. (2019) (0)
- Treatment with anti-tumour necrosis factor a (TNF alpha) antibody improves clinical parameters and lowers portal pressure in alcoholic hepatitis (2003) (0)
- [212] BRAIN SWELLING AND COMA IN CIRRHOTIC RATS ADMINISTERED ENDOTOXIN IS ASSOCIATED WITH INCREASED PROTEIN NITROSATION (2007) (0)
- TREATMENT OF HYPERAMMONEMIA WITH L-ORNITHINE PHENYLACETATE (OCR-002) REDUCES PORTAL PRESSURE BY MODULATING HEPATIC NF kappa B AND HEPATIC ENOS ACTIVITY IN CIRRHOTIC RATS (2009) (0)
- Fluxomics reveals cellular and molecular basis of increased renal ammoniagenesis (2022) (0)
- From the Editor's desk....: November 2018. (2018) (0)
- Acute liver failure (0)
- PWE-267 Urinary TLR4: a novel biomarker to identify patients with acute kidney injury in patients with acute on chronic liver failure (2012) (0)
- [250] THE EFFECTS OF TEZOSENTAN, AN ENDOTHELIN RECEPTOR ANTAGONIST, ON RENAL FUNCTION IN PATIENTS WITH CIRRHOSIS COMPLICATED BY ASCITES AND HEPATORENAL SYNDROME (2007) (0)
- Faculty Opinions recommendation of Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction. (2020) (0)
- The analysis of acetaminophen ( paracetamol ) and 7 metabolites in rat , pig and human 1 plasma by U ( H ) PLC-MS 2 (2020) (0)
- Big title: DAAs reduce post-transplant mortality Cirrhosis (small title): Autoimmune Hepatitis: A familial disease? LIVER INJURY α1-antitrypsin deficiency (A1ATD) induces hepatocyte ER and inflammatory signals, protective role of CARD6 against hepatic ischemia/reperfusion injury A1ATD is an autosoma (2018) (0)
- Correspondence (2003) (0)
- Is “Gilbert's” the culprit in indinavir‐induced hyperbilirubinemia? (2002) (0)
- Big title: NAFLD and coronary artery disease Small title (Cirrhosis): Plectin and cholestasis When achieving SVR is futile Antiviral properties of toll-like receptor 7 agonists ACUTE LIVER INJURY Involvement of hepatocyte interleukin (IL)-1 receptor in early lipopolysaccharide (LPS)-induced liver in (2018) (0)
- Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis (2016) (0)
- From the Editor's desk...: March 2017. (2017) (0)
- Acute-on-chronic liver failure is characterised by hepatocyte gasdermin D cleavage and release of the pro-inflammatory Damage Associated Molecular Pattern (DAMP) IL-α (2018) (0)
- Reply (2003) (0)
- P340 ALBUMIN EXCHANGE AND ENDOTOXIN REMOVAL USING THE NOVEL UCL-LIVER DIALYSIS DEVICE (UCL-LDD) PROLONGS SURVIVAL IN ACETAMINOPHEN-INDUCED ACUTE LIVER FAILURE (ALF) (2014) (0)
- Epidemiology : Patients with Cirrhosis Requiring Intensive Care (2011) (0)
- Clif-C ALF Score is a New Prognostic Tool to Identify Liver Transplant Candidates in Patients with Paracetamol Related Acute Liver Failure and it can Predict the Futility of Liver Transplantation (2016) (0)
- From the Editor's desk...: November 2015. (2015) (0)
- Liver failure (2020) (0)
- Effects Q1 of Albumin Q2 Treatment Q3 on Systemic and Portal Hemodynamics and Systemic In fl ammation in Patients With Decompensated Cirrhosis (2019) (0)
- From the Editor's desk...: December 2017. (2017) (0)
- Faculty Opinions recommendation of Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis. (2020) (0)
- PS-101-Inhibition of toll-like receptor 4 using TAK-242 is a novel therapy for prevention and treatment of acute-on-chronic liver failure (2019) (0)
- SAT-033-Body fat composition determines outcomes before and after liver transplantation in cirrhosis (2019) (0)
- Monocytes exhibit an immune and metabolic reprogramming during acute-on-chronic-liver-failure (2017) (0)
- Ornithine phenylacetate revisited (2013) (0)
- L-Ornithine Phenylacetate (OCR-002) Ameliorates Portal Hypertension by Modulating NFKB Driven Inflammatory Pathway in Cirrhosis (2014) (0)
- Big Title: PNPLA3 increases risk of death in alcoholic hepatitis Small title: Carvedilol increases survival of decompensated cirrhosis patients LIVER INJURIES Thymic MAP3K14 and liver homeostasis, deciphering chemotherapy-related liver injuries (CALI) (2017) (0)
- Editorial: The Role of Myeloid-Derived Cells in the Progression of Liver Disease (2019) (0)
- Porto- systemic shunt embolization and recurrent ascites:a single centre case series (2018) (0)
- Neutrophil dysfunction is potentially predictive of mortality and multi-organ failure in acute decompensation and acute-on-chronic liver failure patients (2017) (0)
- PMO-091 TLR 9 inhibition: a novel target of therapy for primary liver cancer (2012) (0)
- Demonstration of dysfunction in neutrophil phagocytosis in stable cirrhosis using a novel in vivo model of inflammation (2009) (0)
- Evidence of significant oxidative stress and free radical activity in alcoholic hepatitis (2001) (0)
- 773 REDUCTION IN AMMONIA WITH L-ORNITHINE, PHENYLACETATE (OP) BUT NOT ANTI-TNF PREVENTS LPS INDUCED BRAIN EDEMA IN BILE-DUCT LIGATED CIRRHOTIC RATS (2009) (0)
- P34 The mechanism behind synergistic action of l-ornithine and phenylacetate to reduce ammonia in bile-duct ligation rats (2010) (0)
- Brain Glymphatic Clearance is Impaired in a Rat Model of Cirrhosis (2017) (0)
- Neuropsychological and behavioural characterisation of a fully-reversible acetaminophen-induced model of hepatic encephalopathy (HE) in mice (2005) (0)
- Faculty Opinions recommendation of Specific gut and salivary microbiota patterns are linked with different cognitive testing strategies in minimal hepatic encephalopathy. (2020) (0)
- Altered Portal Venous flow response to terlipressin in BDL rats, measured non-invasively using phase-contrast MRI (2013) (0)
- OP09 TIPS outcomes for refractory ascites: a single centre experience (2011) (0)
- OVERNIGHT GLUCOSE INFUSION SUPPRESSES HYPERGLUCAGONEMIA AND REDUCES RENAL AMMONIAGENESIS IN CIRRHOTIC PATIENTS (2008) (0)
- P0171 : Invasive fungal infections in patients with cirrhosis - subanalysis of the fungal infection risk evaluation (FIRE) study (2015) (0)
- Recombinant Alkaline Phosphatase Prevents Acute on Chronic Liver Failure (2020) (0)
- P24 L-ORNITHINE PHENYLACETATE REDUCES AMMONIA IN PIGS WITH ACUTE LIVER FAILURE THROUGH PHENYLACETYLGLYCINE FORMATION: A NOVEL AMMONIA-LOWERING PATHWAY (2014) (0)
- Reply to: Failure to control variceal bleeding: definition matters. (2021) (0)
- 611 PROGRESSION OF HEMODYNAMIC CHANGES IN LIVER CIRRHOSIS. A MATHEMATICAL APPROACH (2011) (0)
- Liver-gut-kidney interaction in liver failure: Novel insights into pathophysiology of hepatorenal syndrome (2011) (0)
- An Unusual Case of Hematochezia (2020) (0)
- Bilirubin and its dynamics are independently associated with mortality in patients with acute decompensation of cirrhosis (2022) (0)
- Albumin as a potential therapeutic agent in Alzheimer's disease (2014) (0)
- RECENT ADVANCES IN CLINICAL PRACTICE PROSPECTS FOR EXTRACORPOREAL LIVER SUPPORT (2004) (0)
- Letter: de novo infection in hepatic encephalopathy—The culprit or the victim? Authors' reply (2022) (0)
- Artificial Liver Support for the treatment of complications of Cirrhosis (2008) (0)
- L-Ornithine Phenylacetate (2016) (0)
- Title : Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury (2015) (0)
- Changes in Plasma Biogenic Amines after Transjugular Intrahepatic Portosystemic Stent-Shunt and Their Potential Role in Hepatic Encephalopathy. (1997) (0)
- Letter to the Editor - Reply to 'Ammonia - an old friend with a new area of application. (2022) (0)
- Soluble CD163 plasma concentration is related with necroinflammatory activity and liver function impairment in compensated cirrhotic patients and is not related with bacterial translocation (2015) (0)
- 1248 ORAL ADMINISTRATION OF NANOPOROUS CARBONS REDUCE SEVERITY OF NON-ALCOHOLIC STEATOHEPATITIS BY MODULATING HEPATIC KUPFFER CELL FUNCTION: A NOVEL THERAPEUTIC APPROACH (2012) (0)
- Stimulated liver and muscle protein synthesis by intravenous isoleucine supplementation during a simulated variceal bleed in patients with cirrhosis of the liver. (2001) (0)
- P0291 : The oncostatic action of sorafenib on liver cancer cells is changed to an oncolytic effect following pre-treatment with chloroquine: Demonstration of synergy between chloroquine and sorafenib as a potential novel approach to treatment of HCC (2015) (0)
- A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 [65_TD$DIFF] Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis (2018) (0)
- Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with ACLF across Western Europe (2019) (0)
- 537 RESTORATION OF THE L-ARGININE:ADMA RATIO BY L-ARGININE TREATMENT IN BILE DUCT LIGATED RATS RESULTS IN SIGNIFICANT LOWERING OF PORTAL PRESSURE (2010) (0)
- A multi-journal partnership to highlight joint first-authors of manuscripts. (2015) (0)
- Metabolic consequences of an upper gastro-intestinal bleed in patients with cirrhosis (2003) (0)
- Erratum: Lipopolysaccharide-Induced Neutrophil Dysfunction Following Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Insertion is Associated with Organ Failure and Mortality (2018) (0)
- Inhibition of toll-like receptor 4 signaling reduces hyperammonemia by modulating urea cycle function (2020) (0)
- Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation (2022) (0)
- Reply to: Sarcopenia should be evaluated in patients with acute-on-chronic liver failure and candidates to liver transplantation. Reply letter. (2021) (0)
- Faculty Opinions recommendation of Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis. (2020) (0)
- From the Editor's desk.....: February 2017. (2017) (0)
- Caecal ligation and puncture induced sepsis in the rat results in increased brain water content and perimicrovessel oedema (2014) (0)
- 577 ALBUMIN IS CENTRAL IN MEDIATING THE CARDIO-RENAL DYSFUNCTION OF CIRRHOSIS: A STUDY IN ANALBUMINAEMIC RATS (2012) (0)
- Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET) (2023) (0)
- The TLR10 polymorphism rs4129009 is associated to poor 28-day survival in patients with cirrhosis and acute on chronic liver failure precipitated by bacterial infection (2016) (0)
- Reversible spastic paraparesis due to cyclosporin toxicity. (1994) (0)
- TLR-10 Single Nucleotide Polymorphism is Associated to Poor Short Term Survival in Cirrhotic Patients with Acute on Chronic Liver Failure Precipitated by Bacterial Infections (2016) (0)
- GENETIC LIVER DISEASES Gene therapy for acute intermittent porphyria (2016) (0)
- 33 INCREASED NEUTROPHIL TOLL-LIKE-RECEPTOR 2, 4 AND 9 EXPRESSION IN ALCOHOLIC HEPATITIS IS A RESULT OF ITS ACTIVATION RATHER THAN ITS CAUSE (2008) (0)
- P: 39 Modulation of the Urea Cycle Function by Toll-like Receptor 4 Signaling: A Potential Novel Therapeutic Target for Hyperammonemia and Hepatic Encephalopathy (2019) (0)
- Pulmonary vascular clearance of harmful endogenous macromolecules in a porcine model of acute liver failure. (2016) (0)
- Severe alcoholic hepatitis as precipitant for organ failure and ACLF. (2022) (0)
- Ischemia modified albumin predicts mortality in liver disease patients (2007) (0)
- In Memoriam Vinay Sundaram (1978-2022). (2022) (0)
- From the Editor's desk…: April 2018. (2019) (0)
- Novel spin trap findings demonstrating severe oxidative stress in alcoholic hepatitis (2002) (0)
- Differential expression of NOSTRIN splice variants alpha and beta in cirrhotic liver diseases (2005) (0)
- CyberLiver Animal Recognition Test (CL-ART): a novel remote monitoring tool to assess minimal hepatic encephalopathy (2022) (0)
- Journal of Hepatology: The Home of Liver Research, 2015-2019. (2019) (0)
- Systemic and Hepatic hemodynamic dysfunction in patients with acute-on-chronic liver failure is significantly associated with dysregulated inflammation and marked sympathetic nervous system activation (2013) (0)
- From the Editor's desk...: December 2015. (2015) (0)
- PMO-142 Evidence refuting the Trojan-horse hypothesis of brain swelling in acute liver failure: l-type glutaminase is exclusively neuronal (2012) (0)
- Novel therapies in the management of acute episodes of hepatic encephalopathy (2017) (0)
- Faculty Opinions recommendation of The effects of probiotics and symbiotics on risk factors for hepatic encephalopathy: A systematic review. (2020) (0)
- From the Editor's desk....: September 2018. (2018) (0)
- Reply to: "Is obesity a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis?" (2018) (0)
- From the Editor's desk...: March 2016. (2016) (0)
- What Role Should Acute‐on‐Chronic Liver Failure Play in Liver Transplant Prioritization? A Survey of US‐Based Transplant Providers (2021) (0)
- Renal ammonia handling: a role for the ammonium cotransporter NKCC2 in the treatment of hepatic encephalopathy? (2012) (0)
- Recombinant glutamine synthetase reduces ammonia and hepatic fibrosis in in vitro and in vivo models of non-alchoholic fatty liver disease (2020) (0)
- 167 Pre-primed neutrophil oxidative burst is independent of clinical severity and outcome in patients with severe alcoholic liver disease (2003) (0)
- 294 TLR 9 INHIBITION: A NOVEL TARGET OF THERAPY FOR PRIMARY LIVER CANCER (2012) (0)
- Benzodiazepine receptor density is upregulated in CHE but does not correlate with changes in neuropsychological function following administration of flumazenil (FMZ) (1997) (0)
- All that glitters is not gold (2002) (0)
- Risk of mortality in patients with uncontrolled variceal bleeding is determined by the presence and severity of acute on chronic liver failure (ACLF) and early transjugular intrahepatic portosystemic shunt (TIPSS) reduces long term mortality (2020) (0)
- Liver Support Systems (2015) (0)
- From the Editor's desk...: May 2016. (2016) (0)
- Correction: The role of RIPK1 mediated cell death in acute on chronic liver failure (2022) (0)
- Treatment of HE Through Selective Alpha 2A Adrenergic Receptor Antagonism Improves Higher Brain Function in Cirrhosis (2017) (0)
- 248 EVIDENCE REFUTING THE TROJAN-HORSE HYPOTHESIS OF BRAIN SWELLING IN ACUTE LIVER FAILURE: L-TYPE GLUTAMINASE IS EXCLUSIVELY NEURONAL (2012) (0)
- Compositions contenant de l'ornithine et du phenylacetate ou du phenylbutyrate utilisee dans le traitement de l'encephalopathie hepatique (2005) (0)
- From the Editor's Desk…: October 2019. (2019) (0)
- P0163 : Monitoring heart rate variability during acute decompensation predicts mortality and potential risk of recurrent hospitalisation (2015) (0)
- From the Editor's desk.... : December 2016. (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Rajiv Jalan?
Rajiv Jalan is affiliated with the following schools:
